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 Phosphorylase Kinase (PhK) is an essential regulatory enzyme in the glycogenolysis 
cascade. PhK is a large, 16-subunit enzyme complex with the subunit stoichiometry ()4, and 
is subject to extensive regulation by small molecules and reversible phosphorylation. Because 
of its large mass of 1.3 MDa, only limited experimental tools are available to study the structure 
of PhK and elucidate the structural changes that occur within the complex concomitant with 
activation. Therefore, our understanding of the roles of PhK’s subunits in regulating its kinase 
activity is woefully incomplete. The goal of this work was to revisit several aspects of PhK’s 
activity and further explore the roles of the enzyme’s individual subunits. 
         Chemical crosslinking was the principal technique used in these studies because it is 
well-suited to study large, multi-subunit complexes. Using chemical crosslinking, plus additional 
methods, three major discoveries are presented regarding PhK’s activation and substrate 
recognition. First, zero-length oxidative crosslinking was used to selectively study 
conformational changes in the regulatory  subunits, which led to the formulation of a model for 
activation of PhK. The model proposes that modification of the N-terminus of  is key to 
activation of the catalytic  subunit and to conformational changes in the  subunits, which likely 
cause global structural changes in the complex. Secondly, a two-step crosslinking approach 
revealed novel interactions between the regulatory  and  subunits and PhK’s substrate, 
glycogen phosphorylase, establishing the first direct evidence of substrate binding sites on the 
regulatory subunits of the enzyme. Lastly, a temperature-dependent conformational change in 
the  and  subunits was discovered to occur between the standard assay temperature of 30 °C 
and the physiological temperature of 40 °C. This temperature-dependent conformational change 
coincides with a surprising activation of PhK at physiological temperature. 
         Steady progress continues to be made in studying the PhK complex. While the picture is 
still far from complete, this work contributes important details regarding the , , and  subunits 
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and their expanded roles in PhK’s activation and substrate interaction. Further exploration of the 
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Chapter I: Introduction 
Overview  
Glycogen is a highly branched polysaccharide found in many organisms, including 
bacteria, fungi, and mammals. The polysaccharide is composed of D-glucose, linked by 1-4  
glycosidic bonds and 1-6  glycosidic bonds that form branch points every 10-14 residues. 
Glycogen particles can contain up to 55,000 glucose molecules, providing a convenient way to 
store large amounts of cytosolic glucose (1). Large deposits of glycogen are found in the muscle 
and liver tissues of mammals, but smaller amounts of glycogen still play important roles in other 
tissues such as brain, skin, and cancer cells (2-4). In muscle, the fast release of glucose from 
glycogen helps sustain muscle contraction. In liver tissue, glycogen is catabolized between 
meals to maintain blood glucose levels. In the brain, glycogen is found in both neurons and 
astrocytes, and its metabolism is essential for memory formation and synaptic plasticity (5, 6). 
Emerging evidence also suggests glycogen metabolism is important for cancer cell growth and 
angiogenesis (7, 8). The function and regulation of glycogen throughout the body remains an 
active and fascinating field of study. 
 Studying the regulation of glycogen metabolism is essential to understanding the diverse 
roles glycogen plays throughout the body. Several enzymes are responsible for the coordinated 
synthesis and degradation of glycogen. Mutations in many of these enzymes, including their 
tissue specific isoforms, result in diseases characterized by dysfunctional glycogen storage and 
diverse phenotypes, such as exercise intolerance, growth retardation, and hepatomegaly, to 
name a few (1). Collectively, these diseases are known as glycogen storage diseases and affect 
thousands of people around the world (9, 10).  
Degradation of glycogen will be the focus herein, with particular emphasis on two 
proteins critical for glycogen catabolism. In the cytosol, glucose-1-P is released from the non-
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reducing ends of glycogen by glycogen phosphorylase (GP) (11). GP is regulated by allosteric 
effectors and reversible phosphorylation by phosphorylase kinase (PhK) (reviewed in (12)). 
Despite GP and PhK being two of the earliest enzymes characterized in the burgeoning field of 
biochemistry during the 1940s and 1950s, questions still surround GP and PhK, including their 
interaction with each other. Further investigation into GP and PhK continues to fill the gaps in 
our understanding, revealing important details on the strict cellular regulation of glycogen 
metabolism. 
Glycogen Phosphorylase 
GP is the enzyme responsible for the phosphorolysis of the non-reducing ends of 
glycogen in the cytosol, releasing glucose-1-P for the cell’s use (Figure 1.1). GP is a member of 
the large glycosyl hydrolase family of enzymes and is sub-classified alongside 
glucosyltransferases that act on α-1,4 glycosidic linkages. In addition to the α-1,4 glycosidic 
linkages, glycogen also contains α-1,6 branch sites, therefore the complete degradation of 
glycogen also requires glycogen debranching enzyme, which removes the α-1,6 branch sites 
during catabolism (13). The sequence and structure of GP is highly conserved, and its 
homologs are found in all branches of life, from E.coli to humans (14). Three isoforms of GP 
(muscle, liver, and brain) are found in mammals, and they share 80-83% identity (15). Muscle 
GP is the most thoroughly studied isoform, and is well characterized in terms of its structure, 
activity, and regulation. GP was one of the earliest enzymes to be studied, and it remains an 
important focus of investigation today. Developing inhibitors of GP as a way of blocking 


























 GP is a dimer of two identical subunits, each containing 843 amino acids (Figure 
1.2)(17). The dimer of GP has two distinct faces, a convex side known as the regulatory face 
and a concave side known as the catalytic face as shown in Figure 1.2B (18). The substrate 
binding and active sites are located on the catalytic face of GP, buried in a ~5 Å channel that is 
partially blocked in the inactive state by the 280s loop (19). Also contained within the active site 
channel is a pyridoxal phosphate (PLP) group, an essential cofactor for GP, covalently bound to 
Lys680 (20, 21). Adjacent to the catalytic channel is the nucleotide inhibitor binding site (22). 
The substrate glycogen, in addition to binding to the active site, also binds a secondary site 30 
Å away with a Kd of 1mM (23, 24). This second binding site, called the glycogen storage site, is 
also the site of tetramer formation between two GP dimers, as seen in the abundant x-ray 
crystal structures available for GP (19). GP readily crystallizes, suggesting that tetramer 
formation happens readily at high concentrations, however it is not known if GP tetramers exist 
in vivo. 
 The regulatory face of GP has two allosteric binding sites near the subunit interface. The 
first binding site, called the AMP binding site, binds IMP and glucose-6-P in addition to AMP, the 
main allosteric activator of GP (25, 26). The “new allosteric effector site” binds small molecule 
inhibitors of GP and is located 15 Å away from the AMP binding site (27). The 20 residues at the 
N-terminus of GP are flexible and disordered in the non-activated complex. The first 10 residues 
do not resolve in X-ray crystal structures and residues 11-20 are often poorly ordered (19). 
Additionally, the N-terminus is highly susceptible to proteolytic attack by trypsin or subtilisin, 
supporting the notion that this region is disordered (28). Importantly, contained within this 











Figure 1.2 Structure of GP. (A) Ribbon diagram of GP, facing the regulatory side of the dimer. 
The N-termini are shown in blue and the C-termini are shown in red. GP was modeled with I-
TASSER to generate a full-length model (the N-terminal 9 residues do not resolve in the crystal 
structures) and the homodimer was constructer with HADDOCK docking software. (B) Ribbon 
diagram of GP with one subunit in teal and the other in fuchsia. The left model views the 







 GP carries out a rapid equilibrium, random bi-bi kinetic mechanism (30). Inorganic 
phosphate and glycogen bind in the active site channel, and inorganic phosphate undergoes a 
general acidic attack promoted by the 5’ phosphate of PLP, forming a carbocation intermediate 
at the C1 position on the terminal glucosyl residue, cleaving the 1-4 glucosidic bond (31). The 
phosphate undergoes a nucleophilic attack on the carbocation, returning a proton to the PLP 
phosphate, completing the reaction. While glycogen degradation is GP’s physiologically relevant 
activity, the reverse reaction (glycogen synthesis) proceeds readily in the presence of high 
concentrations of glucose-1-P. GP is commonly assayed in the direction of glycogen synthesis 
in vitro (32).  
 PLP is an integral part of GP’s catalytic mechanism, but its role is unique from all other 
known PLP-containing enzymes. It is the phosphate group of PLP utilized in GP, and not the 
Schiff base that is used by all other known PLP-containing enzymes (33). Removal of the PLP 
in GP abolishes activity, but reduction of the Schiff base, which is attached to Lys680, has a 
minimal effect on activity (34). While PLP has an unconventional use in GP, it is found in every 
phosphorylase protein currently known, from yeast to humans.  
Regulation 
Phosphorylation of GP on Ser14 or binding AMP causes activation through significant 
tertiary structural changes at the subunit-subunit interface and quaternary changes that mediate 
the transition from the inactive T state to the active R state (Figure 1.3)(12). Although the bulk of 
GP (~60%) remains unchanged between the T and R states, the N-terminus undergoes 
significant rearrangement. Upon phosphorylation, the N-terminus rotates nearly 120°, switching 











Figure 1.3 Regulation of GP. (A) AMP is an allosteric activator of GP. (B) Reversible 
phosphorylation regulates GP’s activity and is controlled by the action of PhK and protein 
phosphatase 1.  
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subunit interface. This transition is driven by both electrostatic and hydrophobic interactions. 
The N-terminus has several basic residues that interact with an acidic patch on the surface of 
GP, but after phosphorylation, the phosphoserine repels this acidic environment to make 
contact with Arg69 and Arg43 near the interface. The hydrophobic residues surrounding 
phospho-Ser14, Ile13 and Val15, fit into nonpolar pockets at the interface. The rearrangement 
of the N-terminus also alters the AMP binding site located at the subunit interface. In the T state, 
AMP binding is facilitated solely through interactions with the phosphate group of AMP. In the 
phosphorylated R state, additional contacts are made with the ribose and adenine rings of AMP, 
accounting for the 100-fold increase in AMP affinity upon phosphorylation (19). 
 These changes near the subunit interface of GP cause a slight rotation of the two 
subunits (19). Accompanying these quaternary changes is movement of the tower helices on 
the catalytic face. The two tower helices, one from each subunit, cross one another at the 
interface, and in the T state their movement pulls the 280s loop from its location in the R state, 
exposing the active site to the solvent. GP is one of the first enzymes to have the signal 
transduction from effector binding to activation so thoroughly understood at the structural level. 
 Despite promoting similar conformational changes, AMP and phosphorylation do not 
have identical effects on GP. The differences between activation by AMP-binding and 
phosphorylation is even more pronounced among the different tissue isoforms of GP. In the 
case of the muscle isoform of GP, phosphorylated GP is active without AMP, but AMP binding 
can stimulate activity an additional 10-20% (35, 36). Conversely, AMP only weakly activates the 
liver isoform of GP, making phosphorylation the primary method of regulating GP activity in liver 





Phosphorylation of GP 
 Reversible phosphorylation is a key mechanism for regulating GP activity. Despite the 
fact that many targets of protein phosphorylation are often targeted by multiple protein kinases, 
muscle GP is only known to be phosphorylated by one kinase, PhK, in response to the cAMP 
signal cascade. Phosphorylation by only one kinase is somewhat surprising because Ser14 on 
GP is likely to be solvent exposed, easily accessible, and the basic sequence surrounding 
Ser14 resembles the target sequences for multiple kinases, including the cAMP-dependent 
protein kinase (PKA) and protein kinase C. These results may indicate that Ser14 on GP is 
either not as accessible as previously thought or there is structure features near Ser14 that 
sterically block interactions with other kinases. 
Phosphorylase Kinase 
PhK is a large, regulatory kinase in the glycogenolysis cascade. The muscle isoform of 
PhK isolated from the fast-twitch psoas muscle of New Zealand White rabbits has been studied 
for over 60 years. PhK also has an important role in regulating glycogen metabolism in tissues 
other than muscle, such as brain and liver, where different isoforms of PhK are expressed (7, 
39, 40). PhK is notable for several reasons: not only was it the first protein kinase to be isolated 
and characterized in 1955 by Edmond Fischer and Edwin Krebs, its immense size, structure, 
and complex regulation set it apart from all other known protein kinases (41). 
Structure 
The PhK holoenzyme has sixteen subunits, four copies of four distinct subunits: the 
catalytic subunit, , and three regulatory subunits, , , and  (Table 1.1)(42). Altogether, the 
hexadecamer ()4 has a mass of 1.3 MDa, making it nearly a third the size of the eukaryotic 
ribosome. Because of its immense size, PhK has eluded high resolution structural analysis, with 
































































































































































































































































































































































































































































utilizing cryo-electron microscopy (cryoEM), chemical crosslinking, and top-down mass 
spectrometry (MS), have revealed the likely arrangement of the subunits within the complex and 
how their interactions change upon activation (Figure 1.4)(43-46). The PhK hexadecamer is 
composed of two octamers stacked in D2 symmetry, creating a bilobal structure connected by 
four bridges (45). The regulatory  subunits form the central bridge-containing core of the 
protein (47). Around the  core are arrayed trimers of , , and . The , , and  subunits form 
the distal portion of the lobes and can be expressed as soluble, stable trimers (48). Crosslinking 
and top-down MS studies suggest that every subunit within PhK makes physical contact with 
the remaining three types of subunits, creating a complex structural network within the 
holoenzyme (46). 
 Subunit 
 The catalytic site of PhK is located on the  subunit, which has a mass of 45 kDa and is 
separated into two domains: a catalytic domain and a regulatory domain (49). The N-terminal 
catalytic domain spans approximately 300 residues and has a typical protein kinase sequence 
and corresponding bilobal structure. The N-terminal lobe of the kinase is composed of 
predominately  sheets, connected to the larger C-terminal lobe which is composed mostly of  
helices. The hinge between these two lobes creates the conserved ATP binding site and the site 
of catalysis (50). A truncated form of  containing only the catalytic domain has been 
successfully crystallized with and without a bound peptide substrate (51). The  structures have 
revealed important information regarding substrate binding to the PhK active site, including the 
importance of basic residues surrounding the phosphorylation site for interactions with residues 
on  (51).  
The C-terminal regulatory domain of  (CRD) contains two high affinity calmodulin 


















Figure 1.4 PhK Structure. (A) Cryo-EM reconstruction of the non-activated PhK molecule with 
the approximate locations of the four subunits in two of the four protomers (used with 
permission from (46)). (B) Schematic drawing of the PhK hexadecamer to illustrate the D2 
symmetry of the complex. 
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(53). The CRD has also been shown to be proximal to the other two regulatory subunits,  and 
 (54, 55). Crystal structures are not available for full-length ; however computational modeling 
using the threading program I-TASSER suggest the structure of the CRD is similar to the 
regulatory domains of some other CaM-dependent protein kinases (CaMK), such as the death 
associated protein kinase (56).  
 Subunit 
 Although PhK is a member of the CaMK family (42), it is an atypical member because in 
the absence of Ca2+, /CaM remains bound to the complex, unlike other CaM kinases that 
dissociate from CaM without Ca2+ present (57, 58). The integral nature of CaM in PhK may be 
due to an interaction between the third EF hand of  and the  subunit (53). In addition to 
anchoring  regardless of Ca2+ concentrations, the interaction with the EF hand likely explains 
why PhK only binds 3 out of the 4 expected Ca2+ ions for CaM (59). Dimers of  and , which 
have been successfully isolated from the holoenzyme and expressed recombinantly, carry out 
Ca2+ dependent phosphorylation of substrates (60, 61). Isolated  also binds free CaM with high 
affinity (Kd = 25 nM) (62). 
 and  Subunits 
Over 80% of the mass of PhK is composed of the large, regulatory  and  subunits. 
Homologs of one another,  and  have masses of 138 kDa and 125 kDa, respectively (63). 
Based on sequence similarity, both subunits contain calcineurin B-like domains in their C-termini 
and glucoamylase-like domains resembling those of the glycosyl hydrolase family 15 (GH15) in 
their N-termini (64, 65). In the glucoamylase-like domain of the  subunit, the two catalytic 
glutamate residues necessary for GH15 hydrolysis activity are present (64). Additionally,  
binds glycogen and a small amount of glycogen hydrolysis has been observed (66). Both 
subunits are the target of effectors and reversible phosphorylation. The phosphorylation sites 
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are located in unique regions of the homologous subunits. Phosphorylation of the unique N-
terminus of  is a key regulatory event in PhK activation, and is targeted by autophosphorylation 
and PKA phosphorylation (63). The  subunit contains a short multiphosphorylation sequence in 
its C-terminus (67).  
Catalytic Mechanism 
 PhK catalyzes the transfer of the  phosphoryl group of ATP to a hydroxyl group on a 
target protein (Figure 1.5). Thus far, all known protein kinases proceed via a sequential 
mechanism, with the phosphate group being transferred directly from ATP to the substrate, as 
opposed to forming a phospho-enzyme intermediate (68). Whether the substrate binding is 
ordered or random appears to be dependent on the individual kinase. In the case of PKA, 
binding is random, but with a bias towards ATP binding before the protein substrate (50). For 
PhK, a random mechanism has been reported, suggesting that ATP and GP may bind in either 
order (69). Kinetic mechanisms appear to differ from one kinase to another, ruling out the 
possibility for a universal mechanism to describe all kinases. Additionally, several aspects of the 
kinase reaction have still not been resolved, including the reaction intermediate (associative vs 
dissociative) and the role of several universally conserved residues in the kinase active site (50, 
68). Given several conserved charged residues in the active site, some postulated that kinases 
utilize general acid-base catalysis to abstract a proton from the target hydroxyl group; however, 
most of the evidence from mutational studies, computational modeling, and kinetics do not 
support this hypothesis (50). The role of the conserved active site residues may instead be to 
orient the substrates and stabilization of the reaction intermediates. The catalytic Asp149 in PhK 
is absolutely conserved, and from crystal structures, interacts with the essential Mg2+ that 
















































































 Kinetic studies on PhK have been relatively sparse and generally disagree with one 
another. There are several reasons for this (see below), but one consequence is a considerable 
range of reported kinetic constants. Previous reports support a rapid equilibrium, random bi-bi 
mechanism for PhK (69, 71). A more recent report by Skamnaki et al. (70) argues against a 
rapid equilibrium, but the reported Michaelis constant for GP is still similar to those reported 
previously (5 μM compared to 20 μM) (Table 1.2). With full length GP as substrate, the reported 
Km values for phospho-activated PhK range from 5.5 μM to 125 μM (72, 73).  
 Two reasons for the discrepancies in reported kinetic values are 1) PhK’s non-linear 
activity and 2) differences in assay conditions between studies. Non-activated PhK has a lag in 
activity (enzymatic hysteresis) (74), precluding analysis using Michaelis-Menten kinetics, which 
requires linear initial activity. Thus, most kinetic studies with PhK have been performed on the 
activated complex, which has no hysteretic behavior. The lag was initially thought to be due to 
auto-activation of PhK by phosphorylation or complex dissociation, but later results suggest that 
the hysteresis is likely due to a slow conformational change caused by binding divalent cations 
(75). Whether activation of PhK changes its Vmax or Km values is not known because of the 
hysteretic behavior of non-activated PhK. Krebs and Fischer postulated in 1964 (74) that a 
change in Km for GP gives rise to PhK activation, but this has been challenged several times. A 
Km effect is also inconsistent with the supersaturating amounts of GP present in muscle cells, 
making Km changes practically irrelevant in vivo (76, 77). A later publication by Newsholme (73), 
suggest a Vmax effect associated with PhK activation. 
 Experiments performed with PhK, kinetic experiments in particular, vary considerably in 
their design and composition from one report to another. Some experiments utilize the 
hexademcameric PhK complex, others truncated , with either full length GP or peptide 
substrates. PhK’s activity is sensitive to multiple factors that often vary between studies 

















Table 1.2 Km and Kd Values Reported for PhK







20 M Yes 36 M 
Initial Velocity 
Kinetics 
Skamnaki et al 
(70) 
ND No 5 M 
Viscosity 
Experiments 
Xu (110) ND ND 2-40 nM ELISA 
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pH, Mg2+ concentration, salt concentration and temperature (78-81). These differences likely 
contribute to some of the differences among reports.  
 Substrates 
 PhK catalyzes a bimolecular reaction between MgATP and a protein substrate and the 
products of this reaction are MgADP and a phosphorylated protein. MgATP has a Km value of 
0.20mM at pH 7.5 for activated PhK (69). In the case of PKA, ADP release is slow and the rate-
limiting step (82), however it is not clear if the rate limiting step for PhK is also ADP/product 
release.  
GP is considered to be PhK’s primary target in vivo, however, in vitro PhK 
phosphorylates several other protein targets. Glycogen synthase is phosphorylated by PhK 
nearly as well as GP, but because synthase is the target of multiple protein kinases, the 
biologically significant PhK phosphorylation is unknown (83). Other PhK substrates include the 
regulatory  and  subunits of PhK (via autophosphorylation), myosin light chain, troponin, tau, 
neurogranin, and water (ATPase activity) (84-88). These additional substrates of PhK are 
phosphorylated at a much slower rate than GP or glycogen synthase and paradoxically, ATP-
analog affinity labels cause variable rates of inactivation depending on which protein substrate 
is being used (89). Additionally, peptide substrates stimulate auto-phosphorylation of PhK, even 
at high peptide concentrations, when one would expect to see competitive inhibition (90). These 
results, along with other seemingly paradoxical findings, led to an early hypothesis that PhK had 
two distinct active sites (reviewed in (91)). Today, we know there is only the one kinase active 
site on the  subunit, but the explanation for the dissimilar behavior towards two distinct groups 




 The importance of the amino acid sequence surrounding Ser14 on GP for PhK 
phosphorylation has been studied in great detail, usually with synthetic peptides. One key 
characteristic of the N-terminus of GP is the four basic residues surrounding Ser14, making PhK 
a basophilic kinase. Peptide studies have revealed a critical role for Arg16, in that charge 
removal or reversal of Arg16 cause a large reduction in PhK phosphorylation of the peptide (72). 
Peptides with an Ala substitution for Arg16 are equally good substrates for PKA and PhK (92). 
Furthermore, although full length wild-type GP is not a substrate for PKA, an R16A GP mutant 
can be slowly phosphorylated by PKA (93). This suggests that Arg16 plays an important role in 
selecting for phosphorylation by PhK, but not PKA. Mutation of any of the residues proximal to 
Ser14 typically produced a peptide that was a poorer substrate than the wild-type peptide (72). 
The corresponding point mutations of full length GP were also poorer substrates than wild-type, 
but the difference was less pronounced than observed with the peptide mutants (93).  
 Peptide studies based on known protein substrates are valuable but inherently biased by 
the existing sequences of known substrates. To study the unbiased, optimal target sequences 
for kinases, the Cantley group designed an oriented peptide library screening approach (94). 
The optimized sequence for PhK from the peptide library had Phe and Met residues flanking the 
phopshoryaltable serine and did not resemble the phosphorylation site on GP. Although this 
unusual sequence may be optimized for PhK phosphorylation, it lacks the context of the intact 
GP molecule, which may assist with substrate binding and phosphorylation. What the optimized 
peptide does reveal is the necessary flexibility near the active site of  to accommodate 
significantly different sequences, which is further supported by the observation that PhK can 
phosphorylate the CaM binding peptide mellitin (95). When the sequence of mellitin is compared 
to the GP sequence, it is only when mellitin is viewed from the C- to N-terminus that the 
sequences align, raising the possibility that  may be able to bind a substrate sequence in the 




 PhK is subject to a high degree of regulation, from small molecule effectors to reversible 
phosphorylation (reviewed in (96)). Given PhK’s large size, one might question why a single-
function enzyme like PhK requires and has evolved such a complex structure. One possibility is 
that PhK acts as a signaling hub for regulating glycogen degradation, evolving multiple 
regulatory sites to respond to diverse cell signaling pathways (hormonal, neuronal, and 
metabolic) (Figure 1.6). Alternatively, PhK may have additional functions or protein targets that 
are currently unknown, potentially in tissues other than muscle.  
 A truncated form of  that contains only the catalytic domain, either expressed 
recombinantly or proteolytically derived from muscle PhK, is constitutively active and Ca2+/CaM-
independent (97, 98). Unlike other kinases that require phosphorylation of the activation loop 
near the active site for activation, Glu182 on the activation loop of PhK appears to obviate the 
need for phosphorylation (51). In contrast, the homologous residue on PKA, Thr197, requires 
phosphorylation in order to become active (51). Furthermore, truncated  has the same specific 
activity as maximally activated PhK, arguing for auto-inhibition of  in the non-activated 
hexadecameric complex. The role of the regulatory subunits and domains of PhK, which 
account for 90% of the enzyme’s mass, inhibit the activity of  in the holoenzyme through 
quaternary constraints (99, 100). A common mechanism in kinases is for an auto-inhibitory 
sequence to block enzyme activity and PhK contains several potential auto-inhibitory segments: 
two sequences in the CRD and one in the  subunit that inhibit  as peptides (52, 101). All 















Figure 1.6 PhK Regulation. Muscle PhK is regulated by several different signaling pathways, 
including neuronal, hormonal, and metabolic signals.  
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proximal to the CRD, which reportedly acts as an allosteric switch mediating signals from the 
regulatory subunits to the nearby active site (55). 
 Ca2+ is absolutely required for PhK activity and Ca2+ binding is mediated by the  subunit 
of PhK (42). Ca2+ has also been shown to cause global conformational changes to the PhK 
complex (44). In addition to Ca2+, other divalent cations also regulate PhK’s activity. Mg2+ and 
Mn2+ bind at the active site of  and at a second binding site. Free Mg2+ binding to the second 
site on PhK stimulates activity, whereas Mn2+ inhibits PhK (102). While Ca2+ binding is clearly 
mediated by , Mg2+ and Mn2+ likely exert their opposing effects through binding the  subunit 
(102). Mg2+ is also known to cause considerable physiochemical changes to the PhK 
holoenzyme (80). 
 The PhK  and  subunits are the targets of phosphorylation by PKA and by PhK itself. 
Phosphorylation of the  subunits is key for activation, with the selective dephosphorylation of  
by protein phosphatase 1 leading to inactivation of the enzyme, regardless of the amount of 
phosphate incorporated into the  subunit (103, 104). Phosphorylation of  by PKA happens 
rapidly, incorporating 1 mol phosphate per mol of  while phosphorylation of  rises gradually, 
eventually incorporating multiple phosphates per mol of  (104). The phosphorylation of  
causes an additional increase in PhK activity (104). Autophosphorylation also leads to 
phosphorylation of  and , but whether the phosphorylation sites are the same as those with 
PKA phosphorylation or autophosphorylation occurs in vivo is unclear.  
 In addition to phosphorylation, PhK is activated at pH values above 7.0, reaching a 
maximum at pH 8.2 (74). The ratio of PhK’s GP phosphorylation activity at pH 6.8 (non-
activated) and pH 8.2 (fully-activated) has been the standard method for reporting PhK 
activation for over half a century.  
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Several additional effectors have been reported to regulate PhK’s activity in vitro. ADP is 
an allosteric activator of PhK and has two distinct binding sites on the complex: a high and low 
affinity site (Kd = 2 μM and 17 μM) (79). The allosteric activation site of ADP binding is very 
likely on the  subunits, but the location of the second ADP binding site is less certain (79). In 
addition to ADP, AMP, FAD, and glycogen bind and activate PhK in vitro (105-107). 
 Lastly, PhK is activated in vitro by limited proteolysis by multiple proteases. The  
subunits of PhK are particularly susceptible to digestion, likely due to their exposed location 
near the lobe tips of PhK (108). More recently, PhK has been shown to be the target of caspase 
3 cleavage (109). The relevance of proteolytic cleavage of PhK in vivo is not known. 
 Activation of PhK by Ca2+ binding, phosphorylation, and/or alkaline pH is associated with 
several conformational changes to the complex. Many of the structural changes appear to be 
accompanied by changes in the  subunits. The bridges, composed of the  subunits, appear to 
shift upon activation accompanying global changes in the lobes (44). Contacts among the  
subunits appear to strengthen in the activated complex while interactions between the other 
three subunits appear to weaken (46). Activation of PhK and the corresponding conformational 
changes is clearly a complex process and one that will require further investigation. 
Interaction Between GP and PhK 
Although there is still much we do not know about PhK and GP independently, we know 
even less about their interactions with each another. For example, we still do not know how 
tightly GP binds to PhK, how many GP molecules can bind to a single PhK holoenzyme, or 
whether GP binds to any regulatory regions of PhK.  
Studies on the interactions between PhK and GP are few in number. The sizes of PhK, 
GP, and the complex they form when bound together (>1.5 MDa) are not amenable to many 
traditional binding techniques. Previous attempts to use fluorescence anisotropy, capillary 
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electrophoresis, light scattering, and Hummel-Dreyer chromatography to determine a 
dissociation constant for the PhK-GP complex were not successful (110). One approach utilizing 
a modified ELISA was successful in determining the apparent dissociation constant for the PhK-
GP complex and produced unexpected results (111). GP was detected to tightly bind PhK with 
nanomolar affinity (39.6 nM) that was enhanced 30-fold by Ca2+, Mg2+, and Mn2+ (2.9-5.2 nM). 
Importantly, these results from direct ELISAs agreed with the dissociation constants from 
competition ELISAs, which monitored the PhK-GP interaction in solution.  
This tight nanomolar affinity was unexpected considering published kinetic studies. 
Although it is usually an over-simplification to equate a Michaelis constant with a Kd, if an 
enzyme undergoes a rapid equilibrium bi-bi kinetic mechanism, the Km can equal Kd. From an 
early kinetic study of PhK that reported a rapid-equilibrium for PhK, the apparent Kd for GP was 
36 μM (69). A later kinetic study by Skamnaki et al. (70), defined individual rate constants for the 
PhK reaction using viscosity experiments and although the authors found that PhK did not 
undergo a rapid-equilibrium with substrates, the Kd calculated directly from their rate constants 
was 5uM. The apparent Kd values based on these kinetic studies (5 and 36 μM) are 1000-fold 
higher than the Kd values from the ELISAs (Table 1.2)(69, 70). The reason for the 1000-fold 
discrepancy between the binding affinity from the ELISA study and the kinetic studies is not 
known. Application of new methods to measure PhK and GP binding will hopefully resolve this 
discrepancy in the future.  
Details on the physical binding sites on PhK and GP for each other have not been well 
defined. The interactions between an enzyme and its protein substrate can be subdivided into 
two kinds of interactions. The first is the physical contacts made at the active site between the 
atoms or bonds to be modified and the surrounding residues that help position or stabilize the 
reaction. The other type of interactions are all those physically separated from the active site. 
These distal interactions can serve important functions in substrate recognition and binding 
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(112). Distal interactions are generally specific to a given kinase-substrate pair and are less well 
studied than active site interactions. For most kinases, including PhK, consensus sequences 
that encompass the active site interactions have been identified after years of work with peptide 
substrates but little is known about distal contact sites and their significance. 
The ELISA studies discussed above also revealed important information about potential 
distal contact sites between PhK and GP. GP’, which lacks the N-terminal 16-18 residues, binds 
to PhK with nanomolar affinity, but does not bind to isolated  (113). These results suggest PhK 
has distal contact sites for GP (apart from the obligatory interaction between the N-terminus of 
GP and ) and that these sites may be responsible for the nanomolar affinity binding detected in 
the ELISA experiments. It is not known where the GP docking site(s) reside on PhK, but yeast 
two-hybrid experiments have suggested that the  subunit of PhK may bind to GP and isolated 
/CaM has been shown to bind an N-terminal fragment of GP (114, 115). A previous report 
utilizing fluorescence polarization postulated that two molecules of the GP dimer may bind to 
PhK, however, given the short half-life of the fluorescence label utilized, it is unclear whether 
these results are accurate (116). Low resolution cryoEM experiments have been performed on 
PhK + GP, but sample heterogeneity, uncertainty in the percent GP bound, and unintended 
proteolysis of the PhK molecule complicate the interpretation of these results (117). Even so, 
with GP bound, the density of the lobes appear to increase, suggesting that GP is binding to the 
distal portions of the lobes which are composed of , , and  as opposed to the central bridge 
region of PhK that is composed of the  subunits.  
In muscle cells, both GP and PhK are likely associated with the glycogen particle (118). 
Andreeva et al. (119) proposed that glycogen, PhK, and GP form a ternary complex, in which 
both enzymes are bound to each other and glycogen, PhK through its  subunits and GP 
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through its storage sites. The authors suggest that binding to glycogen may promote the 
interaction between PhK and GP.  
 Despite the clear challenges facing researchers studying PhK and GP together, their 
interaction is absolutely essential to the cellular degradation of glycogen and warrants continued 
effort to understand their complex interaction. 
Research Aims 
In the six decades since its discovery in 1955, a great deal has been discovered 
regarding the structure, regulation, and activity of PhK. Nevertheless, PhK remains an important 
target of investigation, especially given the emerging roles for glycogen metabolism in diseases 
like cancer and diabetes (3, 4, 16). Furthermore, as techniques in structural biology continue to 
improve and expand, working with difficult, complex structures like PhK becomes more feasible. 
Several key questions still remain regarding multiple aspects of PhK’s activity. The work 
presented herein seeks to address three of these outstanding questions and is outlined below. 
1) How is phosphorylation of PhK associated with activation of  and conformational 
changes in the  subunits? 
2) What regulatory subunits of PhK are involved in GP binding? 
3) How are PhK’s activity, conformation, and interaction with GP altered when investigated 
under more physiological conditions? 
In addressing these questions, valuable insight into the activity of PhK and its essential 





Chapter II: A model for activation of the hexadecameric phosphorylase 
kinase complex deduced form zero-length oxidative crosslinking 
This chapter has previously been published in whole without any adaptations since publication and is 
reprinted with permission. Thompson, J. A., Nadeau, O. W., Carlson, G. M. (2015) A model for activation 
of the hexadecameric phosphorylase kinase complex deduced from zero-length oxidative crosslinking. 
Protein Sci. 24, 1956-63. 
Introduction 
Phosphorylase kinase (PhK) is a key regulatory enzyme in the glycogenolysis cascade, 
catalyzing the Ca2+-dependent phosphorylation and activation of glycogen phosphorylase in 
response to neural, hormonal, and metabolic signals (96). PhK, a member of the Ca2+/CaM-
dependent protein kinase family, is a 1.3 MDa hexadecamer composed of 4 copies of 4 
subunits, , ,  and . In non-activated PhK the regulatory ,  and  subunits exert quaternary 
constraint on the catalytic  subunit, inhibiting its kinase activity (59, 100). Release of this 
constraint, i.e., activation, is achieved through phosphorylation by cAMP-dependent protein 
kinase, principally within the N-terminus of the  subunit (104). 
Because of its large size and heterogeneous post-translational modifications, a high 
resolution structure is not available for PhK. Low to moderate resolution methods for structure 
determination, such as electron microscopy, small-angle X-ray scattering, native MS, chemical 
crosslinking and partial proteolysis, have illuminated approximate subunit locations and 
interactions in the PhK complex (45-47). The large, regulatory  subunits have been localized to 
the core of the complex, forming four central bridges that connect two octameric lobes [i.e., 
2()2] (47).  
One goal of our work has been to elucidate the structural mechanism for activation of the 
PhK complex by phosphorylation. Proximal regions of the  and  subunits have been shown to 
be structurally and functionally coupled, in that activators of PhK, including phosphorylation, 
increase solvent accessibility of epitopes on both subunits (120). Moreover, phosphorylation 
promotes global conformational changes in PhK that alter interactions among the  subunits 
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within its 4 core and between its  and  subunits (46, 122). A large body of evidence points to 
the N-terminus of  as an important regulatory region in the structural and functional coupling of 
 and . This region of  contains two phosphorylatable serines, 11 and 26, whose 
phosphorylation is associated with activation of the kinase (55, 63, 104, 123). Two approaches 
have shown that within the PhK complex the N-terminus of  is proximal to both the C-terminal 
regulatory domain of  (CRD) and to its active site. First, Lys303 within the CRD is crosslinked 
to Arg18 at the N-terminus of  by N-[-maleimidobutyrloxy]succinimide ester (GMBS) (55). 
Second, autophosphorylation at the N-terminus of  occurs intramolecularly (124), indicating 
that this region of  can bind directly to the active site of . The interaction of the N-terminus of  
with the  subunit has also been studied using a synthetic peptide corresponding to the N-
terminal 22 residues of  (referred to herein as the N peptide), which contains the 
phosphorylatable Ser11. N peptide inhibited phospho-activated PhK; and when present during 
crosslinking with GMBS, N not only blocked crosslinking of  to , but was itself crosslinked to 
the same Lys in the CRD as was the  subunit (55). These results indicate that the N peptide 
is a true mimetic of the N-terminus of , competing for the same binding site(s) within the PhK 
complex. Phosphorylation of Ser11 on N blocked the peptide’s ability to inhibit phospho-
activated PhK (55).  
Given that previous work suggested that the N-terminal region of  influenced both - 
and - interactions in the PhK complex, our goal in this current study was to directly examine 
the effect on  self-association of disruption of the - interaction by the N peptide. This 
approach required a highly selective crosslinker capable of forming - dimers in reasonable 
amounts within the intact PhK hexadecamer. Oxidative crosslinking, an emerging tool for 
studying protein-protein interactions (125), was the technique that was used to capture the - 
dimers. Oxidation of susceptible side chains can lead to reactive centers that are readily 
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attacked by nearby nucleophiles, creating zero-length crosslinks within a protein (126). The 
general oxidizing agent periodate was selected for this study because it was found to be highly 
selective and efficient in crosslinking PhK.  
Results 
Characterization of the Products of Periodate Crosslinking 
Periodate oxidation of PhK led to formation of three new species: a high molecular mass 
(~180 kDa) crosslinked conjugate running slower than the heaviest subunit of PhK, and two low 
molecular mass species migrating slightly slower than the  subunit (Figure 2.1). The 
crosslinked heavy conjugate was determined to be intramolecular, as opposed to intermolecular 
(i.e., formed within one PhK hexadecamer as opposed to between two), based on co-elution of 
the crosslinked PhK with the native enzyme on a size exclusion column (data not shown). 
Because common buffer components are potentially susceptible to oxidation, we performed 
control reactions with alternative buffers and without sucrose and found that periodate still 
formed the same reaction products to the same extent, indicating that the modification of PhK 
was directly caused by periodate as opposed to a byproduct of periodate-oxidized buffer 
components.  
The compositions of the three new species were determined using densitometry, 
apparent molecular masses, Western blot analyses, and N-terminal sequencing. The time-
course of crosslinking shows a time-dependent loss of the monomeric  and  subunits, while 
the heavy crosslinked species appears at a rate similar to the loss of  before approaching a 
plateau at 15 min (Figure 2.1). The  and  subunits, on the other hand, show no change in 
density over time, and 
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Figure 2.1 Time-dependent modification of PhK by periodate.  (A) Coomassie stained 6-18% 
SDS-PAGE, time course of crosslinking.  (B) Percent change in the densities over time of the 




thus manifest no evidence of participation in the periodate crosslinking. The apparent molecular 
mass of the heavy conjugate (180 kDa) is consistent with a -dimer (theoretical 220 kDa) or a 
-trimer (theoretical 190 kDa). It should be noted, however, that crosslinked proteins may 
display a smaller apparent mass than the simple sum of their individual components due either 
to crosslinking in central regions of the polypeptides or to additional intra-polypeptide chain 
crosslinking, both leading to smaller effective Stokes radii and thus faster migration. Western 
blots of the periodate-modified enzyme, using subunit-specific monoclonal antibodies for , , 
and  (Figure 2.2), revealed the heavy conjugate to be composed of only , consistent with a -
dimer. The three new species were N-terminally sequenced, and  was detected with high 
confidence in the two lighter bands only. The  subunit is acetylated at its N-terminus (63) and 
thus was not detected. To further confirm that the heavy conjugate is a -dimer,  was 
phosphorylated to a known extent by PKA and the resultant PhK crosslinked with periodate. If it 
is a -dimer, the specific radioactivity of the crosslinked product should be equivalent to the 
specific radioactivity of the monomeric . If instead the heavy conjugate is composed of  and , 
its specific radioactivity would be expected to be lower than monomeric . The specific 
radioactivities of the heavy conjugate and the  monomer corresponded, indicating that the 
heavy conjugate is composed entirely of  (data not shown). We therefore concluded that the 
heavy molecular mass species is a -dimer. 
The cause of the plateau in - crosslinking after approximately 15 min is unknown. 
Although virtually all of the native  is modified, over 50% of the monomeric  remains (Figure 
2.1). Importantly, addition of more periodate after crosslinking reached its plateau did not cause 
more -dimer to form, indicating that the plateau is not due to exhaustion of the periodate but 
instead to an inability of the remaining  to be crosslinked. This could be explained by the 
presence of a subpopulation of  that is exclusively targeted by periodate, or alternatively 
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oxidation of  over time leading to modification of the same amino acid residues that would have 
otherwise participated in crosslinking. We think that this second possibility is highly possible, 
given that at least 8 different amino acids can be oxidized by periodate (see Discussion). 
Oxidation of any of these residues would be occurring simultaneously with, and could compete 
with, a crosslinking reaction by forming an oxidized dead-end side chain incapable of 
crosslinking. 
The two low molecular mass species formed by periodate oxidation appear to be 
composed entirely of  (Figure 2.2). The apparent molecular masses of these two species are 
43 and 45 kDa, or two and 4 kDa heavier than native , respectively. Although the increase in 
apparent mass is consistent with conjugation with a small peptide, we found no evidence for 
this. The oxidative modification of  likely causes the anomalous gel migration, as has been 
seen with oxidation of superoxide dismutase and is analogous to the altered migration 
frequently observed with other proteins after their phosphorylation (127, 128). 
PhK Effectors and  Crosslinking 
Several small molecules, such as divalent cations and nucleotides, bind to PhK and 
modulate its activity by bringing about conformational changes in the enzyme complex. 
Nucleoside diphosphates, in particular, are hypothesized to target the  subunit and promote 
conformational changes within the -core of the enzyme (79). We therefore crosslinked PhK 
with periodate in the presence of four known effectors: Mg2+, Ca2+, deoxyADP and deoxyGDP. 
Deoxyribonucleotides were used instead of ribonucleotides to avoid oxidative cleavage of the 
ribose ring by periodate. Removal of the 3’ hydroxyl group from ADP does not significantly 
change its activating effect on PhK (79). Surprisingly, we found that -dimer formation was 
unchanged in the presence of these four known PhK effectors. There are several potential 
reasons for this, including the possibility that 
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Figure 2.2 Immunodetection of the , , and  subunits in the products of periodate 
crosslinking of PhK for 10 min. 1, Native PhK; 2, Crosslinked PhK. 
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the crosslinked region of the two  subunits does not change in the presence of these specific 
effectors, despite other conformational changes taking place elsewhere in the  subunits, as 
indicated by past studies (44, 120). Another possibility is that the effector binding sites on the 
enzyme are being oxidized, altering or eliminating binding before an effect on crosslinking is 
seen.  
N Peptides and  Crosslinking 
The  subunits are the structural and regulatory core of the PhK enzyme complex (47), 
and their N-termini have been shown to crosslink to the catalytic  subunit, although the 
crosslinker used was relatively long (55). The synthetic N peptide inhibited that - crosslinking 
and was, in fact, crosslinked to  itself, i.e., even within the PhK complex it mimics and 
competes with the N-termini of the  subunits to which it corresponds (55). Importantly, N 
inhibits the kinase activity of phospho-activated PhK, but not that of non-activated PhK, while 
phospho-N inhibits neither form of the kinase (55). The sum of these results suggests that 
phosphorylation of the N-terminal region of  diminishes its interaction with . Given that 
phosphorylation of the N-terminus of  also promotes  self-association (46, 122), we 
hypothesized that the N peptide, by mimicking and competing with the N-termini of the  
subunits, would disrupt - interactions in the non-activated (non-phosphorylated) holoenzyme 
complex, thus inducing an increase in -dimer formation by periodate. As predicted, periodate 
crosslinking of PhK in the presence of the N peptide caused an increase in -dimer formation 
(Figure 2.3). Also as expected, phosphorylated N peptide was considerably less effective in 
promoting -dimer formation (Figure 2.3), which is consistent with our hypothesis that 
phosphorylation of the peptide inhibits its ability to compete with the native N-terminus of  in 
interacting with the  subunit.  
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Figure 2.3 N peptide and periodate crosslinking of the  subuntis of PhK.  (A) SDS-PAGE 
of PhK treated with 500 M periodate for 2.5 min in the presence of the N peptide or 
phosphorylated N peptide (1 mol γ: 100 mol peptide).  (B) Density of the  and - 
bands for the different conditions.  The  densities are normalized to the monomeric  in 
native PhK and the - densities are normalized to the - in control crosslinked PhK (Xlink).  




Herein we report the selective crosslinking of the large regulatory  subunits of PhK by 
the general oxidizing agent periodate. Although this oxidant is frequently used to cleave the 
carbon-carbon bond between vicinal hydroxyl groups in saccharides, we have successfully used 
low concentrations of periodate (≥10 µM) to oxidize susceptible amino acid side chains and thus 
introduce a zero-length crosslink into the hexadecameric structure of non-activated PhK, 
allowing the study of  subunit interactions. Although it would be useful to know the exact amino 
acids in  that are crosslinked, which we have achieved with other PhK crosslinkers (55, 129), 
that would not be trivial with periodate, given that it likely modifies numerous residues not 
involved in crosslinking. Periodate has been reported to oxidize the side chains of Tyr, Met, Trp, 
Cys, Asp, Asn, Arg and His (130, 131), but the only crosslink that has been characterized is a 
3,3’-dityrosine that it formed in ovotransferrin (132, 133). A variety of crosslinking reagents has 
been successfully used to study subunit interactions in PhK, but only two of these have been 
zero-length, forming -, - and - dimers (53, 134, 135). Zero-length crosslinkers are 
desirable because they demonstrate that two subunits directly interact, as opposed to being 
only proximal. The only crosslinker previously shown to be selective for PhK’s  subunits was 
1,5-difluoro-2,4-dinitrobenzene (DFDNB), which has a 3-5 Å spacer arm and also forms - 
dimers, but only in small amounts and only with activated  conformers of PhK (79, 122). 
Because the four  subunits form the four central bridges that interconnect PhK’s 2 lobes (45, 
47), the -dimers formed by periodate or DFDNB could be either intralobal or interlobal, as the 
subunits could potentially interact with each other within or across each lobe. Although we do 
not know the specific regions of  that DFDNB and periodate crosslink to form -dimers, it is 
likely that they target distinct areas of the subunit given their different responses to effectors of 
PhK on their crosslinking (122).  
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 The quaternary structure of non-activated PhK inhibits the activity of its catalytic  
subunit (i.e., quaternary constraint) (100, 136, 137), and subunit interactions within the complex 
are altered concomitant with enzyme activation (i.e., relief of quaternary constraint) (46, 54, 55, 
122). Overall, subunit interactions within the PhK complex are destabilized by phosphorylation, 
except for those of its  subunits, whose self-association is strengthened (46), and it is the 
phosphorylation of  that is the key activator of PhK (104, 137). Within the hexadecameric PhK 
complex, regions of the  and  subunits have been shown to be not only proximal (55), but to 
be structurally coupled to each other and with enzyme activation (120). Moreover, in native MS, 
- dimers are observed only in phospho-activated PhK, whereas - dimers are present in only 
non-activated PhK (46). Thus, findings using multiple techniques link the phosphorylation of the 
N-terminus of  with activation of  and increased self-association of . The initiator of these 
linked events is the phosphorylation of the N-terminus of , and this region has, in fact, been 
shown to control  dimerization. In yeast two-hybrid experiments designed to detect self-
association of  to form homo-dimers, no self-association was observed with full-length ; 
however, removal of the first 31 residues from its N-terminus or phospho-mimetic Ser→Glu 
mutations in the N-terminus of full length  both led to homo-dimerization (55). So, how might 
phosphorylation of this region of  relate to activation of ? In addition to its being zero-length, 
another major utility of periodate’s crosslinking of PhK is that it targets a region of  that is 
sensitive to the interactions of its N-terminus (Figure 2.3), the site at which activating 
phosphorylation occurs. The sum of the above facts allows construction of a theoretical low 
resolution structural model for the activation of PhK by phosphorylation.  
In this model (Figure 2.4), we envision for the non-activated enzyme a direct interaction 
between the  subunit and the N-terminus of . This - interaction can be thought of as an 
equilibrium between the non-activated state of PhK (intact - interaction and weak  subunit 
association) and an activated state (no, or limited, interaction between  and the N-terminus of  
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and enhanced  subunit self-association). In the non-phosphorylated enzyme, the - interaction 
would stabilize the non-activated state of  (Figure 2.4A). The above scenario is consistent with 
the findings that both the N-terminus of  and the N peptide crosslink to the C-terminal 
regulatory region of , albeit with a 7.3-10 Å crosslinker (55). Previously, from results with 
peptide mimetics, the N-terminus of  has been hypothesized to inhibit non-activated PhK 
through either a direct or indirect interaction with  (55, 138). In our model, successful 
competition of the N peptide for the binding site on  for the N-terminus of the  subunit would 
free that N-terminus and thus strengthen  self-association (Figures 2.3 and 2.4B); however, the 
 subunit would remain in the non-activated state because it would still have the N peptide 
bound to it (Figure 2.4B). Consistent with this last point, the N peptide has no effect on the 
activity of non-phosphorylated PhK (55). Phosphorylation of the N peptide is predicted to 
impair its binding to , thus it would compete poorly with the N-terminus of the  subunit, leaving 
 in the non-activated state and not strongly promoting  self-association (Figures 2.3 and 2.4C). 
Finally, we propose that phosphorylation of the N-terminus of  at Ser11 or Ser26 disrupts the 
- interaction, again leading to activation of  and enhanced  self-association (Figure 2.4D). 
Our model predicts that the N peptide could readily bind to the  subunit in this state and bring 
about inhibition, which is the case (55). It should be noted that in this model enhanced  self-
association is a consequence of activation, not its cause. It is attenuation of the interaction 
between the catalytic  subunit and the N-terminus of  that gives 
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Figure 2.4 Model for Activation of PhK.  We propose a model for activation of PhK mediated 
by the phosphorylatable N-terminus of the large, regulatory  subunits.  In the non-activated 
enzyme complex (A), the unphosphorylated N-terminus of  interacts with the γ subunit, 
inhibiting kinase activity.  In the presence of a competing peptide (N), or phosphorylation, 
the N-terminus of  loses strong contact with γ and promotes self-association of the  
subunits (B and D).  The phosphorylated N peptide does not compete as well for the 
interaction with γ (C). 
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rise to activation and the concomitant -dimerization detected by periodate oxidation. Thus, -
dimers can be formed independently of activation when the N peptide competes with and 
displaces the N-terminus of the  subunit from  (Figure 2.3). 
Materials and Methods 
PhK and N Peptide 
Non-activated PhK was purified from the psoas muscle of female New Zealand White 
rabbits, dialyzed into 50 mM HEPES (pH 6.8), 0.2 mM EDTA, and 10% sucrose (w/v), and 
stored at -80 °C (75). The concentration of PhK was determined spectrophotometrically at 280 
nm using an absorbance coefficient of 1.24 mL mg-1cm-1 (137). The N and phosphorylated N 
peptides were purchased from Biopeptide (San Diego, CA), and their purity and composition 
verified by both MS and MS/MS analyses using a MALDI 4700 mass spectrometer in the Mass 
Spectrometry Facility of the University of Kansas Medical Center.  
Oxidative Crosslinking 
Sodium meta-periodate (99.8+%, CAS No. 7790-28-5) was used as received from Acros 
Organics. Non-activated PhK was incubated at 30 °C for 2 min before periodate was added to 
initiate the crosslinking reaction. The standard final reaction mixture contained 20 mM HEPES 
(pH 6.8), 0.1 mM EDTA, 500 M periodate and 1.35 M  PhK protomer. When present, the 
peptide concentration was 135 M. At appropriate times, aliquots of the reactions were removed 
and quenched in 125 mM Tris, 20% (v/v) glycerol, 5% (v/v) -mercaptoethanol, 4% (w/v) SDS, 
and trace Coomassie R250 (pH 6.8). Quenched samples were run on 6-18% gradient 
polyacrylamide gels, followed by staining with R250 Coomassie (0.1%) and Bismark Brown 
(0.02%) in 7% acetic acid and 40% methanol. Gels were destained in 7% acetic acid and 5% 
methanol. Crosslinking reactions were carried out at least in triplicate with multiple preparations 
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of PhK to confirm the reproducibility of the crosslinking. The density of the PhK subunits and 
crosslinked species was determined using ImageJ software (139).  
To prepare phospho-activated PhK for crosslinking, the phosphorylation reaction (total 
volume of 80 L) contained 54 mM -glycerophosphate (pH 7.0), 0.5 mM EGTA, 0.01 mM DTT, 
50 mM NaF, 1.5 mM Mg(OAc)2, 0.25 mM [-32P] ATP, 750 g/mL PhK, and 2 g/mL PKA 
(murine catalytic subunit, New England Biolabs, Cat. No. P6000L). The reaction was initiated by 
addition of MgATP, run at 30 °C for 1 min, and quenched with 20 mM EDTA. The phosphate 
incorporation into  was 4x that into  (0.32 vs. 0.083 mol P/ mol subunit). The quenched, 
phosphorylated PhK was immediately diluted into buffer containing a final concentration of 510 
M periodate and 437 g/mL PhK. Crosslinking was carried out for 10 min at 30 °C and 
quenched in SDS buffer. After running the samples on a 6-18% polyacrylamide gel, staining, 
and destaining, the , , and crosslinked product bands were excised, decolorized in 350 L 
30% H2O2 at 104 °C for 1 h, and diluted in 4 mL scintillation fluid. The specific radioactivity of 
the bands were compared between crosslinked and non-crosslinked phospho-activated PhK.  
Apparent Molecular Mass Determination 
The apparent molecular masses of the crosslinked products were determined based on 
the relative mobilities on SDS-PAGE gels of the native PhK subunits and protein standards. 
Using a broad range, molecular mass marker mix from Bio Rad (cat no. 161-0318), the relative 
mobility was plotted against the log of the molecular mass for each protein or subunit. The 
resulting line had an R value of 0.99 and the corresponding linear equation was used to 
calculate the molecular mass of the crosslinked species from its relative mobility. For the 
theoretical masses of a -dimer and a -trimer, the apparent molecular masses of each 
subunit were used, i.e. the mass based on the relative mobility and not the actual mass of the 




Samples for immunodetection were transferred from the SDS-PAGE gels to PVDF 
membranes and blocked with 5% (w/v) nonfat, powdered milk, PBS (0.14 M NaCl, 2.7 mM KCl, 
6 mM Pi) (pH 7.4), 0.1% Tween20, and 0.2% gelatin. The primary mAbs against the , , and  
subunits of PhK have been previously characterized and were used as described (43, 120). 
Colorimetric detection of the immunoreactive bands was performed with AP-conjugated 
secondary antibodies from Southern Biotechnology. 
N-Terminal Sequencing 
Crosslinked PhK was run on SDS-PAGE, blotted onto PVDF, and stained with Ponceau 
S before the bands were excised and submitted to the Harvard University Mass Spectrometry 







Chapter III: The regulatory  and  subunits of phosphorylase kinase 
directly interact with its substrate, glycogen phosphorylase 
A portion of this chapter has previously been published and is reprinted here with permission. Thompson, 
J. A., Carlson, G. M. (2017) The regulatory  and  subunits of phosphorylase kinase directly interact with 
its substrate, glycogen phosphorylase. Biochem Biophys Res Commun. 482, 221-5. 
Introduction 
The breakdown of glycogen is mediated by phosphorylase kinase (PhK) and glycogen 
phosphorylase (GP). PhK phosphorylates a single serine on GP, causing activation and 
subsequent phosphorolysis of glycogen to release glucose-1-P (140). PhK is also regulated by 
reversible phosphorylation, and both GP and PhK are also regulated by a variety of allosteric 
effectors (rev in (12, 141)). This complex regulation of PhK and GP is consistent with their large 
masses. PhK is a hexadecameric complex having four copies of four different subunits (, ,  
and ) and a total mass of 1.3 MDa (42). The  subunit (44.7 kDa (49)) is catalytic, and the 
remaining three subunits,  (138.4 kDa (67)),  (125.2 kDa (63)) and  (16.7 kDa (142)), are 
regulatory (100), with the  subunit being a molecule of non-dissociable calmodulin (42). The 
substrate GP is a homodimer of 197 kDa (29). The GP dimer has two distinct faces: a convex 
regulatory face, where the phosphorylatable serine and allosteric binding sites reside, and a 
concave catalytic face (18). 
The recognition of protein substrates by kinases can be complex. The selective 
phosphorylation of protein substrates depends not only on having appropriate amino acids 
surrounding the residue to be phosphorylated (primary structure), but also frequently on docking 
site interactions distinct from the phosphorylation site(s) (112). After decades of extensive work 
with peptide substrates, consensus amino acid sequences preferred by most kinases are 
reasonably well-defined, but docking site interactions between kinases and their substrates are 
by comparison poorly understood (112, 144, 145). These distinct contact points often play 
important roles in substrate recognition and phosphorylation (144, 145). 
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Unlike most other kinases, PhK has only one recognized physiological target, GP. 
Moreover, GP is known to be phosphorylated only by PhK, making this an unusually specific 
kinase-substrate pair. Despite this unusual specificity and the importance of these two enzymes, 
little is known regarding the physical interaction between PhK and GP, and their large sizes 
complicates traditional binding and structural studies. We know that the N-terminus of GP, 
which contains its single phosphorylation site, must bind to the active site of  to be 
phosphorylated, and the crystal structure of truncated  with a bound peptide substrate reveals 
details of this binding (51). Importantly, the only comprehensive binding studies on the 
interactions between PhK and GP found that GP lacking its phosphorylatable N-terminus still 
bound to PhK with a similar affinity as full-length GP (113), suggesting additional contact site(s). 
Yeast two-hybrid studies raised the possibility that a C-terminal region the regulatory  subunit 
(residues 864-1014) of PhK may interact with the N-terminal half of GP (residues 17-484) (114). 
Calmodulin, PhK’s  subunit, has also been shown to bind an N-terminal fragment of GP (115). 
Only the  subunit has not been previously implicated in the binding of GP. Here we report the 
use of short chemical crosslinkers to unambiguously show direct interactions between GP and 
the two large regulatory subunits of PhK,  and .  
Results and Discussion 
Identifying GP-PhK crosslinkers 
To limit the amount of crosslinking, a two-step crosslinking approach was used to 
capture interactions between GP and the subunits of PhK. This approach involved pre-labeling 
GP with a low concentration of crosslinker (step 1) immediately prior to incubation with PhK 
(step 2). The pre-labeling of GP preferentially captured conjugates between PhK and GP before 
intramolecular crosslinking within the GP dimer or PhK hexadecamer could dominate. Of seven 
different crosslinking reagents screened using this two-step method, four (sulfosuccinimidyl 4,4'-
azipentanoate; bis(sulfosuccinimidyl)suberate; N-α-maleimidoacet-oxysuccinimide ester; and 
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formaldehyde) failed to capture GP-PhK conjugates, but three (1,5-difluoro-2,4-dinitrobenzene 
(DFDNB), succinimidyl iodoacetate (SIA), and N-5-azido-2-nitrobenzoyloxysuccinimide (ANB-
NOS)) successfully did so.  
Several major products are formed from DFDNB crosslinking of GP and PhK. The two 
most intense crosslinked bands are intramolecular PhK products, formed with or without GP 
present (Figure 3.1A, lane 4). One is a slower migrating - conjugate, and the other is an intra-
subunit crosslink of  (Figure 3.1B). When DFDNB, PhK and GP are present together, two new 
bands form below the - product (Figure 3.1A, lane 3), the slower being a doublet that cross-
reacts with anti-GP and anti- antibodies, identifying it as a GP- conjugate. The faster 
migrating band is a GP- conjugate. There are additional PhK-GP products above the - band; 
however, these are not well-defined, and their composition is difficult to confidently identify by 
Western blot due to their proximity to one another. Finally, GP undergoes a small amount of 
inter-subunit crosslinking to form three, faint bands (Figure 3.1A, lane 2).  
Another crosslinking reagent, SIA, also formed GP-PhK conjugates (Figure 3.2A). While 
GP and PhK were both independently crosslinked by SIA (Figure 3.2A, lanes 1 and 3), when 
they were present together, three new products formed (lane 2). Western blotting identified the 
products as the conjugates of GP-, GP-, and a second, faster migrating GP- (GP-F) (Figure 
3.2A, bottom panel). The GP- product is a doublet, like the GP- formed by DFDNB, 
suggesting that multiple sites are crosslinked between GP and . 
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Figure 3.1 DFDNB crosslinking of GP and PhK. (A) Coomassie stained 4-12% SDS-
PAGE gel with control and crosslinked PhK ± GP. Lane 1 is PhK and GP without DFDNB 
crosslinking. PhK or GP were crosslinked individually to determine intramolecular 
crosslinking by DFDNB (lanes 2 and 4). Lane 3 has both GP and PhK present with 
DFDNB. (B) Amido black staining and Western blot of PhK and GP crosslinked together 
by DFDNB. Previously characterized antibodies to GP and the , , and  subunits of 
PhK were used to identify the conjugate species (43, 111, 120). i, intra-subunit crosslink 
of . ’, a naturally occurring splice variant of the  subunit. 
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Figure 3.2 SIA and DFDNB crosslinking of GP and PhK. (A) Coomassie-stained 4-12% 
SDS-PAGE gel and Western blot analysis of SIA crosslinking products. (B), same as (A) but 
with ANB-NOS crosslinking. (C), Side-by-side comparison of the co-migrating GP- and GP-




ANB-NOS, the third crosslinker that formed GP-PhK conjugates, required a different 
crosslinking approach than used with DFDNB and SIA. ANB-NOS is a photosensitive 
crosslinker, containing one functional group that remains inert until activated by UV light. 
Therefore, GP was labeled in the dark by the amine-selective group on ANB-NOS, and 
unreacted ANB-NOS was removed by gel filtration prior to incubation of the modified GP with 
PhK. UV light then activated the second functional group on the crosslinker, allowing it to react 
with bound PhK. Like SIA, ANB-NOS formed three GP-PhK conjugates (Figure 3.2B), which 
were identified by Western blots as another GP- doublet, and two GP- products.  
Thus, three different crosslinking reagents apparently form the same GP-PhK 
conjugates (Figure 3.2C). In the case of the GP- doublet and the slower migrating GP-, these 
conjugates co-migrate for all three crosslinkers. The faster migrating GP-F appears with SIA 
and ANB-NOS, but not DFDNB. The consistent formation of these products suggests that the 
same interfaces between GP and regions of  and  are being sampled by the different 
crosslinkers and represent genuine contact points between GP and PhK. Moreover, the short 
spacer lengths of the crosslinkers (1.5 – 7.7 Å) further argues for direct contact of GP with  and 
. Our results are consistent with earlier predictions of direct interactions between GP and the 
regulatory subunits of PhK based on binding studies. GP lacking its phosphorylatable N-
terminus binds to PhK in a competitive ELISA assay, but fails to bind the isolated catalytic 
subunit (113), suggesting that the regulatory subunits of PhK may be involved in the binding of 
GP. Our results also agree with a previous yeast two-hybrid study that suggested an interaction 
between GP and PhK’s  subunit (114). A direct interaction between GP and the  subunit has 
not been previously suggested. It is feasible that interactions may also occur between GP and 
PhK’s small, regulatory  subunit (115), but we were unable to test for the presence of  in 
crosslinked conjugates due to the lack of an effective antibody for calmodulin. 
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Our results directly establish for the first time that there are interactions between GP and 
regulatory subunits of PhK. The location and function of these newfound interactions may be 
involved in the unusually selective phosphorylation of GP by PhK, because an isolated form of 
the catalytic  subunit lacking its calmodulin-binding C-terminus phosphorylates GP less 
effectively than does  within the PhK activated complex. Based on at least five published 
studies, the average kcat for isolated, truncated  is 56 sec-1 (S.D. ± 26) (69, 73, 117, 146), 
whereas the average kcat for activated PhK is 245 sec-1 (S.D. ± 119) (70, 93, 117, 147-149). 
Although different laboratories and conditions undoubtedly account for some differences in the 
kcat values, the reported average value for  within PhK is nevertheless 4.4-fold greater than that 
of truncated . Thus, despite their inhibition of the  subunit in non-activated PhK (100), it is 
possible that the  and  subunits contribute to the catalytic efficiency of  in the activated 
complex. The Km values for GP in the above studies are too scattered to allow a meaningful 
determination of the specificity constants (kcat/Km) for the two forms of . 
Additional binding sites, distinct from the active site, have been identified in other kinase-
substrate pairs. Such sites could enhance the interaction between the substrate and active site 
through several mechanisms (144, 150). For example, regions on GP adjacent in 3D structure 
to its phosphorylation site could bind to  and  and properly position GP’s N-terminus at the 
active site of . Alternatively, GP could also bind  and  at a more distant site, anchoring GP to 
PhK and increasing the frequency of interaction between GP’s N-terminus and the active site. 
Similar docking or recruitment strategies have been seen with other kinases, including MAPK 
and cyclin-dependent kinases (151, 152). Another possibility is that GP binding to the regulatory 
subunits could stabilize a conformation of PhK that promotes phosphorylation through allosteric 
activation or improved substrate binding, as is seen with PDK1 and MAPK (112, 153). 
GP may also bind to  and/or  at a second binding site, completely removed from the 
active site of PhK. A secondary binding site for GP on the PhK complex, not associated with  
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and phosphorylation, is unprecedented but presents an attractive hypothesis to explain some of 
the odd and paradoxical features of PhK’s interaction with GP. The most striking of these 
oddities is the 100-fold difference in apparent affinities reported from binding and kinetic studies. 
The apparent binding affinity for PhK and GP, as measured by a competitive ELISA, was 
reported to be 29.8 + 1.3 nM (111) while the Kd derived directly from kinetic rate constants was 
5 M (70). These two very different apparent affinities may reflect two separate GP binding sites 
on PhK: a low affinity binding site near the active site and a separate high affinity site on the 
regulatory subunits. Furthermore, PhK and GP are present in muscle cells at unusually high 
concentrations, constituting together over 2% of the soluble protein (105, 154). Under these 
conditions, PhK can phosphorylate all of the GP in just a fraction of a second (155). These high 
concentrations could potentially drive GP binding to both high and low affinity sites on PhK. The 
function of a hypothetical second GP binding site is unknown but could be involved in protein 
folding, stability, or localization of GP and PhK to the glycogen particle. The  and  subunits of 
PhK may therefore be playing the part of scaffolding proteins, which are used widely by other 
kinases to localize to their substrates (145, 156). Future work will test the existence of a 
secondary binding site for GP on PhK and its potential function. 
Prior to this, only PhK’s catalytic  subunit was known with certainty to bind GP; 
however, we did not detect any crosslinking between GP and . Active site interactions of 
protein kinases with their substrates have been suggested to be transient, facilitating rapid 
turnover (50, 144). Thus, it may be that the interaction between GP and  is too transient for 
detection by chemical crosslinking compared to the potentially more stable interactions between 





Effectors and GP-PhK crosslinking 
Because in vitro phosphorylation of GP by PhK requires Ca2+ and MgATP (Mg2+ in 
excess), we determined the effects of these ligands on formation of GP- and GP- conjugates 
during crosslinking with DFDNB. To avoid autophosphorylation, we substituted the 
nonhydrolyzable analogue adenylyl-imidodiphosphate (AMP-PNP) for ATP. The concentrations 
of AMP-PNP and Ca2+ used were 10-fold above their reported Kd values (58, 157), whereas 
Mg2+ was at a concentration only 6.7-fold above its reported Ka value (158), because of the 
tendency of PhK to aggregate in the presence of high concentrations of this cation (80). We 
found that AMP-PNP without divalent cations completely blocked formation of the GP- and 
GP- conjugates (Figure 3.3, compare lanes 4 and 1), whereas inclusion of Mg2+ and Ca2+ with 
AMP-PNP partially overcame its protection against formation of the GP-PhK conjugates 
(compare lanes 4 and 6). Control experiments showed that pre-incubation of AMP-PNP and the 
cations with DFDNB had no effect on its subsequent reactivity (data not shown), indicating that 
the effects of these ligands on GP-PhK conjugate formation are due to their direct interactions 
with at least one of the proteins.  
Adenine nucleotide affinity labels modify the ,  and  subunits of PhK (159-161), and 
ATP and AMP-PNP bind with similar affinity to  and an allosteric site (157), most likely on  
(159, 160). At higher concentrations, ATP also binds an allosteric site on GP; however, under 
our conditions, the predicted occupation of the allosteric site by AMP-PNP is sub-saturating 
(162). Thus, the complete inhibition of GP- and GP- formation by AMP-PNP likely results 




Figure 3.3 DFDNB crosslinking under various conditions. PhK and GP were crosslinked with 
DFDNB for 5 min in the presence of various effectors after pre-incubation of GP with DFDNB 
for 2 min. (A) Coomassie-stained GP- and GP- conjugates on 4-12% SDS-PAGE gel after 
crosslinking in the presence of the indicated small molecules. (B) Densities of GP- and GP-
 after crosslinking in the absence or presence of effectors and normalized through dividing 
by the average density of the control GP- conjugate. Error bars represent the standard 
deviation of triplicate samples. The lanes in part (A) came from the same experiment and 
gel. ND, none detected. 
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binding sites on  and . It must be noted, however, that decreased crosslinking does not 
necessarily indicate loss of interaction. Crosslinking with a short reagent such as DFDNB 
samples only a small region of the interface between GP and PhK; so, loss of crosslinking could 
be due to even the smallest structural rearrangements in the interface. 
A ligand-induced structural rearrangement is also apparently the reason that both free 
Ca2+ and Mg2+ inhibit formation of GP- and GP- conjugates by DFDNB (Figure 3.3, compare 
lanes 2/3 and 1), given that both of these cations actually enhance PhK’s binding of GP (111). 
Free Mg2+ stimulates PhK’s activity (163) through binding to the  subunit (164); it also induces 
several physiochemical changes in the PhK complex (80). Ca2+ also stimulates PhK’s activity 
(57, 165), but by binding to its regulatory  subunit, an integral molecule of calmodulin (42), and 
Ca2+ brings about global conformational changes throughout the PhK complex (44, 166).  
Influence of Phosphorylation on the GP-PhK Interaction 
PhK and GP are both subject to phosphorylation, which causes conformational changes 
associated with activation in each enzyme. Because the crosslinking between GP and PhK was 
sensitive to effectors necessary for phosphorylation (Ca2+, MgATP), and because the regulatory 
 and  subunits become phosphorylated, phosphorylation of these subunits may influence their 
GP binding sites. Therefore, DFDNB crosslinking between GP and the regulatory subunits of 
phosphorylated PhK (phospho-PhK) was compared to crosslinking with non-activated PhK 
(Figure 3.4). DFDNB crosslinking of the PhK complex alone is known to change considerably 
between non-activated and phospho-PhK, especially in the  subunits (122). As anticipated, 
phosphorylation of PhK caused considerable changes to the observed crosslinking pattern, but 
also led to the disappearance of the GP- and GP- conjugates (Figure 3.4). There are several 




Figure 3.4 DFDNB crosslinking of GP and phospho-PhK. On the left, Coomassie-stained 4-
12% SDS-PAGE of DFDNB crosslinking products of GP and non-activated PhK (lane 1) 
and GP and phospho-PhK (lane 2). PhK was phosphorylated via PKA phosphorylation and 
crosslinked as described under Materials and Methods. Additional DFDNB crosslinking 
products have been noted, including the previously observed  dimers and tetramers 
observed with DFDNB crosslinking of phopsho-PhK (124). On the right, Western blot 
analysis of the GP- and GP- products with non-activated and phopsho-PhK.  
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conformational changes at the GP binding sites on  and  that eliminates the crosslinking. 
Another possibility is that crosslinking of newly exposed sites within phospho-PhK may compete 
for DFDNB crosslinking at the GP binding sites, leading to a reduction or loss of GP-PhK 
products. Finally, the migration of the GP- and GP- conjugates from phopsho-PhK may be 
different than with non-activated PhK, especially if hypothetical trimers of GP-- or GP-- are 
forming instead, which would be difficult to identify due to poor separation of heavy conjugates 
on the SDS-PAGE (>350kDa). Given the fact that phosphorylated PhK must still interact with 
GP in order to phosphorylate it, the change seen in DFDNB crosslinking suggests that 
phosphorylation of PhK may affect how GP is binding to PhK.  
GP binding to the regulatory  and  subunits has unknown consequences on the 
structure and activity of both GP and PhK. Docking of GP on  and  may support its 
phosphorylation by PhK, but the potential impact of this binding on GP’s own conformation is 
equally interesting and completely unknown. Therefore, GP activity was measured in the 
absence and presence of non-activated and phospho-PhK (Figure 3.5A). While non-activated 
PhK appears to slightly inhibit GP’s AMP-dependent activity, phospho-PhK appears to have no 
effect. 
The activity of phosphorylated GP was then measured in the presence and absence of 
non-activated and phospho-PhK (Figure 3.5B). Phosphorylated GP does not require AMP for 
activity, but is further stimulated by AMP binding. Non-activated PhK again appears to inhibit GP 
activity (both AMP-dependent and independent). Phospho-PhK, on the other hand, has 
surprising effects on GP activity. In the absence of AMP, phospho-PhK appears to stimulate 
GP’s activity; but in the presence of AMP, it inhibits activity to the point that activation of 
phosphorylated GP by AMP is nearly abolished. These results suggest that phosphorylation of 
PhK and GP may influence how they interact with one another, consistent with the results from 


























































Figure 3.5 GP activity in the absence and presence of non-activated PhK and phospho-PhK 
(PPhK). (A) GP activity in the absence (black bars) and presence of non-activated PhK 
(black diagonals) or phospho-PhK (white bars). (B) Phosphorylated GP activity in the 
absence (gray bars) and presence of non-activated PhK (gray diagonals) or phospho-PhK 
(white bars). Control GP refers to GP assayed in the absence of PhK. Error bars represent 
the standard deviation of three reactions. The GP assay was performed as described under 





Much will be necessary to uncover the structural details and functional significance of these 
binding sites.  
The results of this work suggest that multiple conformational changes are likely 
associated with the interactions between PhK and GP. That these interactions directly involve 
regulatory subunits of PhK adds an additional layer of complexity to this already complex, highly 
regulated system. A deeper understanding of the interaction between PhK and GP and its 
regulation will help us better understand the strict cellular control of glycogenolysis.  
Materials and Methods 
Enzymes 
Non-activated PhK was purified from New Zealand White rabbit psoas muscle as 
previously described (75), dialyzed into 50 mM HEPES (pH 6.8), 0.2 mM EDTA, and 10% 
sucrose (w/v), and stored at -80 °C. PhK concentration was determined spectrally at 280 nm 
using an absorbance coefficient of 1.24 mL mg-1cm-1 (137). GP was also isolated from New 
Zealand White rabbit muscle as described previously (34), and recrystallized with Mg2+ and 
AMP. After removal of AMP by dialysis into 10 mM HEPES (pH 6.8), GP was stored at -80 °C. 
The concentration of GP was determined spectrally at 280 nm with an absorbance coefficient of 
1.30 mL mg-1cm-1 (167).  
Phospho-PhK was generated by autophosphorylation and PKA phosphorylation for the 
GP activity and crosslinking experiments, respectively. For PKA-phosphorylation, PhK was 
phosphorylated for 5 min at 30 °C. Phosphorylation was initiated by the addition of MgATP and 
the final concentrations were 20 mM Tris/GP (pH6.8), 0.1 mM EDTA, 0.1 mM DTT, 5 μg/mL 
PKA, 1 mg/mL PhK, 5 mM Mg(OAc)2, and 1 mM ATP. The amount of phosphate incorporated 
was approximately 2 mol PO4/mol γ. The reaction was quenched with EDTA to a final 
concentration of 10mM and set on ice before being used directly in a two-step crosslinking with 
GP. Control PhK was treated in an identical manner except for the absence of ATP. For PhK 
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autophopshorylation, the reaction was initiated with addition of MgATP and the reaction 
contained 50 mM HEPES (pH 8.2), 0.05 mM EGTA, 0.1 mM CaCl2, 1 mg/mL PhK, 4 mM 
Mg(OAc)2, and 0.2 mM ATP. Autophosphorylation for 15 min at 30 °C led to the incorporation of 
4 mol PO4/mol γ. The reaction was quenched with EDTA to a final concentration of 10mM 
and kept on ice before use in the GP activity assay. Control PhK was treated in an identical 
manner except for the absence of ATP. 
Phosphorylated GP was formed by phosphorylation by PhK. The reaction was initiated 
by addition of PhK and contained 20 mM Tris/GP (pH 8.2), 0.1 mM EGTA, 0.2 mM CaCl2, 10 
mM Mg(OAc)2, 1.5 mM ATP, and 1 μg/mL PhK. The reaction was run for 30 min at 30 °C at 
which point the amount of phosphate incorporated reached a plateau of 0.7 mol PO4/mol GP. 
The reaction was quenched with EDTA to a final concentration of 10mM and kept on ice before 
use in the GP activity assay. Control GP was treated in the same way, but in the absence of 
ATP.  
Chemical crosslinking 
The crosslinkers DFDNB (CAS No. 327-92-4), SIA (CAS No. 39028-27-8), and ANB-
NOS (CAS No. 60117-35-3) were from Pierce/ThermoFisher Scientific.  
To limit crosslinking, a two-step protocol was used with DFDNB and SIA in the 
crosslinking of GP with PhK. In step one, GP was pre-incubated with crosslinker (135 M 
DFDNB or 540 M SIA) for 2-5 min at room temperature (RT). The pre-incubated GP was 
immediately diluted 10-fold into a solution containing PhK and incubated at 30 °C for 5 min. The 
final concentrations were: 20 mM HEPES (pH 6.8), 0.1 mM EDTA, 437 g/mL PhK, 260 g/mL 
GP, and 13.5 M DFDNB or 54 M SIA (carryover solvent was 0.2% DMSO or ACN). The molar 
ratio of PhK protomer () to GP monomer was 1:2, while the ratio of DFDNB and SIA to GP 
monomer was 5:1 and 20:1, respectively. Reaction aliquots were quenched in an equal volume 
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of SDS buffer (125mM Tris (pH 6.8), 20% glycerol, 5% -mercaptoethanol, 4% SDS, and trace 
Coomassie R250) and analyzed on a 4-12% linear SDS-PAGE gel.  
ANB-NOS, a photo-activated crosslinker, was treated differently than DFDNB and SIA. 
GP was incubated with 100M ANB-NOS for 5 min at RT in the dark. After removal of unreacted 
ANB-NOS on a P10 de-salting column, the labeled GP was incubated at RT with PhK under a 
long-wave UV lamp (366nm) at a distance of 1 cm for 5 min. The crosslinking reaction was 
quenched and analyzed as above.  
When effectors were included in the DFDNB crosslinking reaction, they were added to 
the GP/DFDNB solution 15 sec before addition of PhK. The final concentrations of Mg2+, Ca2+, 
and AMP-PNP in the second step were 4 mM, 330 M, and 300 M, respectively. The density 
of the crosslinked products was determined using ImageJ software (139). To ensure 
reproducibility, three different preparations of PhK were used, and all experiments were 
performed in triplicate.  
Western blotting 
Samples for immunodetection were transferred from SDS-PAGE gels to PVDF 
membranes and blocked with 5% (w/v) nonfat powdered milk in 0.14 M NaCl, 2.7 mM KCl, 6 
mM PO4 (pH 7.4), 0.1% Tween20, and 0.2% gelatin. The primary antibodies against GP and the 
, , and  subunits of PhK have been previously characterized and were used as described 
(43, 111, 120). Colorimetric detection of the immunoreactive bands was performed with AP-
conjugated secondary antibodies from Southern Biotechnology. 
GP Activity 
GP was assayed in the direction of glycogen synthesis by quantifying phosphate cleaved 
from glucose-1-P. The assay was initiated with addition of GP and the final reaction solution 
contained 20 mM MOPS (pH 6.8), 2.5 mM glucose-1-P, 0.1 mg/mL glycogen, 3 mg/mL BSA, 
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and 10 μg/mL GP. When present, the concentration of non-activated or phosphorylated PhK 
was 500 μg/mL. When present, the concentration of AMP was 1 mM. The glycogen, purchased 
from Sigma, was further purified by ethanol precipitation and dialysis to remove contaminating 
nucleotides and phosphate. GP was assayed at 30 °C for 10 min and 2 min for non-
phosphorylated and phosphorylated GP, respectively. To quench the reaction, 20 L aliquots 
were mixed with 1 mL of freshly prepared malachite green reagent (0.12 mM malachite green, 
2.25 mM ammonium molybdate, 830 mM H2SO4, 0.02% PVA). The malachite green reaction 
was allowed to develop for 10 or 12 min and the absorbance at A630 was measured. The color 
development was continuous, so the A630 measurements were carefully timed. A standard 
phosphate curve was generated for each experiment and was linear between 0 and 20 nmol 




Chapter IV: Activation of phosphorylase kinase by physiological 
temperature 
Reprinted with permission from Herrera, J. E., Thompson, J. A., Rimmer, M. A., Nadeau, O. W., Carlson, 
G. M. (2015) Activation of Phosphorylase Kinase by Physiological Temperature. Biochemistry. 54, 7524-
30. Copyright 2015 American Chemical Society. The sections contributed by J.A. Thompson are 
presented in this chapter in full alongside new, never-before published results. 
Introduction 
Phosphorylase kinase (PhK) is a large, regulatory enzyme in the glycogenolysis 
cascade. Decades of research on the PhK hexadecamer ()4 in vitro have revealed much 
about this enzyme’s structure, activity, and regulation. Fischer and Krebs established the 
foundation of PhK research in the 1950’s, and since then, virtually every PhK study has utilized 
the same isoform isolated from the fast-twitch muscle of female New Zealand White rabbits. 
Based on cDNA sequencing, at least four other isoforms of PhK are present in other tissues, 
such as slow-twitch muscle, liver, and brain, that we know very little about (168). In addition to 
the widespread focus on the muscle isoform of PhK, the vast majority of experiments performed 
on the enzyme have been conducted at 30 °C. However, the body temperature of a rabbit is 
nearly 10 °C higher at 39.7 °C.  
Recently, the first report investigating PhK’s kinase activity as a function of temperature 
revealed unexpected activation of PhK at 40 °C (81). PhK’s activity increased ~3.5 fold every 10 
°C between 0 and 30 °C but from 30 to 40 °C, an 8-fold increase in activity was observed 
(Figure 4.1A and B). This deviation from the expected increase in reaction rate is clearly evident 
as a break in the otherwise linear Arrhenius plot (Figure 4.1C). This activation may be caused 
by a temperature-dependent conformational change in the enzyme, consistent with this 
temperature-dependent effect being reversible (Figure 4.1E). The implications of this 



















Figure 4.1 Temperature dependence of GP conversion at pH 6.8. (A) The amount of GP 
converted at a fixed time at each indicated temperature. (B) The fold-change in activity between 
each 10 °C temperature interval (Q10), calculated by dividing the value at the higher 
temperature by that at the lower. (C) Arrhenius plot for the activity shown in Panel A. (D) The 
fold-change in activity at 2 °C temperature intervals (Q2) between 30 and 40 °C, calculated as in 
Panel B. (E) The effects of pre-incubation and assay temperatures on activity. PhK was pre-
incubated for 5 min at either 30 or 40 °C and immediately assayed at both of the same 
temperatures. The pre-incubation and assay temperatures were 30 and 30 °C (open square), 40 
and 30 °C (open circle), 30 and 40 °C (closed square) and 40 and 40 °C (closed circle). Where 
present, the error bars (red) indicate the standard error of triplicate assays and generally did not 
exceed the symbol dimensions. 
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far, activators and inhibitors of PhK appear to have diminished effects on the enzyme at 40 °C 
vs. 30 °C (81). 
One prominent feature of PhK at 40 °C is the near absence of a lag in the product 
formation (i.e., phosphorylation of GP) (Figure 4.1E). Non-activated PhK displays hysteretic 
behavior (140), likely related either to a slow conformational change that accompanies 
activation of the enzyme or to autophosphorylation during the assay. Binding of Ca2+ plus Mg2+ 
and autophosphorylation have both been attributed to causing the hysteretic behavior of PhK 
(75, 90). Activated PhK, assayed at pH 8.2 or phosphorylated by the cAMP-dependent protein 
kinase (PKA), has a linear rate of product formation.  
The near absence of a lag in the PhK reaction at 40 °C creates new opportunities to 
study the kinetics of PhK, especially given the fact that no information currently exists regarding 
PhK kinetics at the physiological temperature of 40 °C, and very little is known about the kinetics 
of non-activated PhK under any conditions, because of its non-linear reaction rate. A previous 
study by Newsholme and Walsh (73) reported kinetic values for non-activated PhK at pH 6.8, 
which is considered the physiological pH for rabbit muscle. The authors claimed to have 
eliminated the lag in activity for non-activated PhK by assaying the enzyme in HEPES buffer, as 
opposed to Tris/GP which is typically used to buffer PhK. When their conditions were repeated 
at 40 °C, however, a lag was clearly present (data not shown). This suggests that instead of 
eliminating the lag, their conditions actually lengthened the lag to the point that the initial velocity 
appeared linear during the timecourse measured.  
 Sixty years’ worth of PhK research can and likely should be re-evaluated in light of the 
enzyme’s surprising activation at 40 °C. To begin, evidence for a temperature-dependent 
conformational change in PhK will be presented followed by kinetic analysis of both the non-





Results and Discussion 
Conformational change in PhK between 30 and 40 °C 
 The surprising rise in PhK activity between 30 and 40 °C may result from a 
conformational change in the enzyme leading to a more active form at the higher temperature. 
However, no evidence of a physical change between 30 and 40 °C was obtained from a variety 
of biophysical techniques including UV absorption spectroscopy, intrinsic Trp fluorescence, far-
UV CD, dynamic light scattering, and differential scanning calorimetry (169). Although no 
structural changes were detected with these techniques, a conformational change is still 
possible for two reasons: these techniques may have missed small, local conformational 
changes in the complex and the strong background signals produced by the massive PhK 
molecule could obscure subtle conformational changes. Attempts to detect a conformational 
change in PhK between 30 and 40 °C therefore shifted to looking for changes in specific regions 
of the hexadecameric complex. PKA phosphorylation of  and  was therefore measured at 30 
and 40 °C to see if PKA distinguished between PhK conformers at the two temperatures (Figure 
4.2). For the  subunit, there was an expected increase in the rate of phosphorylation by PKA 
(275% increase) at 40 °C that one would typically expect due to an increase in temperature from 
30 to 40 °C. In contrast, the  subunit saw only a modest increase in phosphorylation by PKA 
(30% increase) at 40 °C compared to 30 °C. This difference in the rates of phosphorylation 
suggests a conformational change at the phosphorylation sites of  between 30 and 40 °C with 
the higher temperature conformer being a worse substrate for PKA, offsetting the expected 




Figure 4.2 Phosphorylation of the  and  subunits by PKA at 30 and 40 °C. (A) PKA 
phosphorylation of the  subunit at 30 °C (red circles) and 40 °C (red circles). (B) PKA 
phosphorylation of the  subunit at 30 °C (black squares) and 40 °C (red squares). The reaction 
was performed as described under Materials and Methods. Assays were performed in triplicate. 













































To further investigate conformational changes in PhK due to increasing temperature, we 
next turned to chemical crosslinking as a structural probe. Chemical crosslinking has been used 
successfully in the past to detect conformational changes in PhK (53, 54, 135). The short, 
homobifunctional crosslinker 1,5-difluoro-2,4-dinitrobenzene (DFDNB) forms crosslinks between 
three of the four subunits of PhK (, , and ). PhK was therefore incubated with a 50-fold molar 
excess of DFDNB for a fixed amount of time at 10 °C intervals between 0 and 40 °C (Figure 
4.3). The consumption of the subunits by crosslinking was measured by densitometry. The  
subunits showed a steady, unremarkable increase in crosslinking with increasing temperature 
(Figure 4.4). The crosslinking of the  and  subunits, however saw little consumption by 
crosslinking between 0 and 30 °C but between 30 and 40 °C, a dramatic increase in 
consumption of both  and  occurred (Figure 4.4). This suggests that between 30 and 40 °C, 
the  and  subunits undergo a conformational change likely exposing new crosslinking sites 
leading to their hastened modification by DFDNB. It should be noted that the  subunit 
underwent intrasubunit crosslinking by DFDNB, leading to a product running slightly faster on an 
SDS-PAGE gel (Figure 4.3). This intramolecular crosslinked product was included in the 
densitometry measurement for monomeric . As seen in Figure 4.3B, both monomeric  and the 
intramolecular product were consumed at a greatly increased rate at 40 °C. 
The  subunits form the structural core of the PhK hexadecamer, which is arranged as 
two octamers oriented in a head-to-head conformation, with the  subunits forming four 
interconnecting bridges between the octamers (47). Several effectors of PhK alter the 























Figure 4.3 Temperature-dependent crosslinking of PhK by DFDNB. PhK was crosslinked by 
DFDNB as described under Materials and Methods. (A) Non-crosslinked PhK (Cntrl) and PhK 
crosslinked at 0, 10, and 20 °C, and (B) 30 and 40 °C. (C) Immunodetection of the β and α 
subunits in control vs. crosslinked PhK at 0, 10, 20, 30 and 40 °C. Samples from each 
crosslinking temperature used in generating Panels A and B were run on 6-18% gradient gels, 
transferred to PVDF membranes and blocked in 5% milk, 1x PBS, 0.1% Tween20, and 0.2% 
gelatin (pH 7.4). The primary mAbs against the α and β subunits of PhK have been previously 
characterized and were used as described (2, 3). Colorimetric detection of the immunoreactive 





Figure 4.4 Temperature-dependent subunit consumption by DFDNB cross-linking. The percent 
consumption of  (A),  (B) and  (C) after 6 min of crosslinking by a 50-fold molar excess of 
DFDNB at the temperatures indicated. Percent consumption, derived from Figure 4.3, is based 
on the density remaining of the monomeric subunits relative to the density of the unmodified 
subunits from the same concentration of control non-crosslinked enzyme. Error bars represent 



























































































Our results show that activation by temperature appears to be another mechanism for activating 
PhK through the targeting of . 
The  and  subunits of PhK have been shown to be structurally and functionally coupled 
to one another. Immuno-electron microscopy revealed that the epitopes of the  and  subunits 
are adjacent to one another on the interior lobe face of the complex, and activation of the 
complex led to parallel increases in antibody binding to  and  (120). Direct interactions 
between these two subunits have been supported by multiple techniques including chemical 
crosslinking and top-down mass spectrometry (46, 55). The proximity of  to the catalytic  
subunit and the reoccurring observation of  conformational changes upon activation by 
different effectors reiterate the critical role of  in the regulation and activation of PhK. 
DFDNB crosslinking was previously shown to crosslink the regulatory  and  subunits 
of PhK with its substrate glycogen phosphorylase (GP). Given the observation that PhK is likely 
undergoing a conformational change between 30 and 40 °C and DFDNB crosslinking was 
sensitive to this change, it seemed worthwhile to determine if the conformational change at 40 
°C altered the PhK-GP crosslinking. Using the two-step crosslinking methods described in 
Chapter III Materials and Methods, PhK and GP were crosslinked for a fixed amount of time at 
varying temperatures. The first step in crosslinking (treatment of GP with DFDNB) was 
performed at a constant temperature and the second step (10-fold dilution of GP into the PhK 
solution) was performed at 10 °C intervals between 0 and 40 °C. Although crosslinking did 
increase predictably with increasing temperature, no apparent differences in the crosslinking 
pattern were detected at 40 °C (i.e., GP- and GP- conjugate formation remained unchanged) 
(data not shown). 
Kinetics of PhK at Physiological Temperature 
Non-activated PhK has eluded kinetic assessment because of its hysteretic behavior. 
Although PhK’s activity and structure differ between 30 and 40 °C, the near absence of 
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hysteresis allows for the determination of kinetic constants at the physiological temperature and 
a comparison of changes in Km(GP) and Vmax due to phosphorylation.  
Although PhK’s lag was greatly reduced at 40 °C, effort was taken to further minimize it. 
The pH of the assay was therefore raised to 7.2, the top of the physiological range of pH values 
observed in muscle tissue (171). K+ was also included in the assay at physiological 
concentrations and was found to stimulate PhK activity. Previously, anions and to a lesser 
extent cations, of neutral salts were shown to generally inhibit PhK activity (78). The exception, 
however, was (NH4)(CH3CO2) which stimulated PhK (78), similar to the stimulation seen in the 
present studies with K(CH3CO2). With these updated conditions, the activity of PhK was nearly 
linear, especially when compared to the enzyme assayed at 30 °C under the same conditions 
(Figure 4.5). 
Using these conditions, substrate saturation curves were obtained with non-activated 
PhK at 40 °C and phospho-activated PhK at 30 and 40 °C (Figure 4.6). The data were fit using 
non-linear least squares fitting in KaleidaGraph, and the kinetic constants are summarized in 
Table 4.1. Phosphorylation increased the specific activity of PhK at both 30 and 40 °C, but the 
effect was less pronounced at 40 °C. Only modest changes to Km(GP) occurred among the 
conditions tested, implying that activation of PhK by phosphorylation was not accompanied by a 
drastic change in Km. This again challenges the early report by Krebs (74) that suggested 
activation of PhK caused a change in Km for GP, but agrees with a more recent report by 
Newsholme (73) who reported a Vmax change between non-activated and phospho-activated 
PhK. The change in Vmax between non-activated and phospho-activated PhK in the Newsholme 










Figure 4.5 PhK activity at 30 and 40 C. Non-activated PhK was assayed as described under 
Materials and Methods for a 10-min timecourse at 30 C (black circles) and 40 C (red circles) at 









































































































































































































































































































































































































































































































































































































































Table 4.1 Summary of kinetic data for non-activated and phospho-activated PhK at 30 & 40 °C. 
 
Two values are given for each value, indicating the results from independent experiments with 













1.37 + 0.03 
1.76 + 0.05 




4.7 + 0.2 
4.5 + 0.3 
56 + 14 
61 + 20 
7.5 + 1.0 
8.0 + 1.6 
1.22 + 0.12 




4.9 + 0.3 
4.2 + 0.4 
34.6 + 5.3 
37.4 + 5.9 
6.34 + 0.54 
6.53 + 0.63 
1.33 + 0.06 




7.6 + 0.3 
6.8 + 0.4 
58 + 20 
41 + 8 
12.0 + 2.7 
9.35 + 1.1 
1.22 + 0.12 
1.30 + 0.08 
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reported here (60-fold increase vs. 2-fold increase), and is likely due to the fact that our non-
activated PhK at 40 °C has a much higher basal activity than their non-activated enzyme at 30 
°C. 
The data from the saturation curve were fit to both the Michaelis-Menten equation and 
the Hill equation and the error of the calculated constants was compared to determine the 
equation that best fit the data. The Hill equation produced the best fit, which was somewhat 
unexpected because there has been no prior evidence of PhK displaying any cooperative 
binding of GP. PhK does have four catalytic kinase sites per hexadecamer, suggesting that a 
single PhK molecule could bind four molecules of GP. The number of GP molecules that bind to 
PhK at saturation has not been studied in great detail; however, one study suggested that two 
GP dimers bind to one PhK hexadecamer (116). With regard to other PhK ligands, Ca2+ was the 
only one to display any hints of cooperative binding, but those reports contradicted each other, 
with one reporting negative cooperativity and the other showing positive cooperativity (57, 172). 
Ca2+ binds PhK very tightly (Kd = 17 nM) and low amounts of contaminating Ca2+ likely 
complicated those studies. Although the Hill numbers reported here are relatively modest (nH = 
1.29-1.46), these results raise the interesting possibility that one GP binding may affect the 
binding of subsequent GP molecules. 
Does this kinetic data give us more insight into how PhK is regulated in vivo? Perhaps, 
but it is hardly the full story. In these experiments, only a small range of PhK’s activity was 
sampled in order to avoid the problematic lag. The lag was minimized so linear initial velocity 
could be readily measured and fit to classic kinetic analysis, but hysteresis may be an integral 
part of PhK’s activation in vivo. Enzyme hysteresis describes the slow response of an enzyme 
to a rapid change in substrate concentration and manifests as either a lag or burst in product 
formation, depending on whether the enzyme transitions to a more or less active state, 
respectively (173). Hysteresis may be caused by a slow conformational change, oligomerization 
of the protein, or dissociation of subunits induced by effector binding (174). For many hysteretic 
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enzymes, the cause of the hysteresis can be puzzled out by pre-incubation with effectors or 
substrates. PhK’s lag can be equally diminished by different treatments, including auto-
phosphorylation and pre-incubation with Mg2+/Ca2+. PhK’s lag may be more likely due to a slow 
conformational change, based on the observation that sub-complexes of PhK (dimers of  and 
timers of ) do not display hysteresis (48). Additionally, the lag was not specific to GP 
phosphorylation because PhK’s ATPase activity also had a lag in product formation (86). At the 
low intracellular pH levels in exercising muscle, PhK likely has a pronounced lag that may play a 
role in its regulation during muscle contraction. 
The observation that PhK is more active at the physiological temperature of a rabbit has 
important implications for its regulation in vivo. PhK’s basal activity was much higher at 40 °C 
vs. 30 °C; and although phosphorylation and allosteric effectors still stimulate activity, their 
effect is greatly diminished (81). Phosphorylation and allosteric effectors may therefore be more 
important under conditions when the intracellular pH changes and the basal activity of PhK are 
reduced.  
Materials and Methods 
Enzymes 
Non-activated PhK was purified from New Zealand White rabbit psoas muscle as 
previously described (75), dialyzed into 50 mM HEPES (pH 6.8), 0.2 mM EDTA, and 10% 
sucrose (w/v), and stored at -80 °C. PhK concentration was determined spectrally at 280 nm 
using an absorbance coefficient of 1.24 mL mg-1cm-1(137). GP was also isolated from New 
Zealand White rabbit muscle as described previously (34), and recrystallized with Mg2+ and 
AMP. After removal of AMP by dialysis into 10 mM HEPES (pH 6.8), GP was stored at -80 °C. 
The concentration of GP was determined spectrally at 280 nm with an absorbance coefficient of 
1.30 mL mg-1cm-1 (167). The catalytic subunit of murine PKA was from New England Biolabs 
(Ipswich, MA).  [-32P]ATP was purchased from PerkinElmer (Boston, MA). 
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PKA Phosphorylation of PhK 
Quantification of subunit phosphorylation by PKA was carried out as previously 
described (75). The reaction mixtures contained 50 mM GP, 50 mM Tris (pH 6.8), 1 mg/ml 
PhK, 0.5 mM EDTA, 0.04 μg/mL PKA and were initiated with 10 mM Mg(CH3CO2)2 and 0.2 mM 
[-32P]ATP . At the indicated times aliquots were removed, quenched by dilution into reducing 
SDS buffer, run on SDS-PAGE, and phosphorylation quantified. Assays were performed in 
triplicate. 
 Additionally, phospho-activated PhK was generated by PKA phosphorylation for kinetic 
analysis. Phosphorylation was initiated by addition of MgATP into a reaction containing 20 mM 
GP (pH 6.8), 0.1 mM EDTA, 0.1 mM DTT, 2 μg/mL PKA, 550 μg/mL PhK, 5 mM Mg(CH3CO2)2 
and 1.7 mM ATP. The reaction was run at 30 °C for 6 min before quenching with addition of 
EDTA to a final concentration of 10 mM. Approximately 2 mol PO4 is incorporated into the PhK 
protomer.  
Crosslinking 
PhK (437.5 μg/ml) was crosslinked by DFDNB (67 μM) at 10 °C intervals between 0 and 
40 °C in the presence of 50 mM HEPES (pH 6.8) and 0.1 mM EGTA. The reaction was 
quenched after 6 min in a reducing SDS buffer resulting in final concentrations of: 219 μg/mL 
PhK, 63 mM Tris (pH 6.8), 10% glycerol, 2.5% β-mercaptoethanol, 2% SDS, and trace 
Coomassie.  Aliquots were run on 6-18% gradient polyacrylamide gels, followed by staining with 
R250 Coomassie (0.1%) and Bismark Brown (0.02%) in 7% acetic acid and 40% methanol.  
Gels were destained in 7% acetic acid and 5% methanol. Crosslinking reactions were carried 






PhK activity was measured by the incorporation of 32PO4 into GP by a filter paper assay 
(175). The reaction solution was pre-equilibrated for 2 min at the assay temperature and assays 
were initiated by addition of MgATP. The assays contained 20 mM HEPES, 25 mM GP (pH 
7.2), 100 mM K(CH3CO2)2, 0.05 mM EDTA, 0.25 mM CaCl2, 25 mM -mercaptoethanol, 1 mM 
DTT, 10 mM Mg(CH3CO2)2, 2.5 mM [-32P]ATP, 6 mg/mL GP and 0.2 μg/mL PhK. When GP 
concentration was varied (0.78 μM - 100 μM), the concentrations are noted in the figure legend. 
The molecular mass of the GP monomer (97,300 Da) was used to calculate molarity. 
Experiments were run in triplicate on at least two separate preparations of PhK to confirm 
reproducibility. 
Analysis of Kinetic Data 
The kinetic data were analyzed using the KaleidaGraph program to generate a weighted 
least-squares fit of the data. Multiple equations were applied to determine the best fit, and the 
Hill equation best fit the data with the smallest standard errors on the generated kinetic 
constants. Under all conditions, no more than 10% of the GP was phosphorylated by the 





Conclusions and Future Directions 
 
Phosphorylase kinase (PhK) catalyzes the phosphorylation and activation of glycogen 
phosphorylase (GP) as an essential step in the glycogenolysis cascade. Glycogen is present in 
nearly all mammalian tissues and supports a variety of biological processes, such as muscle 
contraction, blood glucose homeostasis, and long-term memory formation. Additionally, 
mutations in glycogen metabolizing enzymes, such as PhK and GP, lead to glycogen storage 
diseases that range in severity depending on the specific mutations and tissue afflicted. 
Continued investigation into the activity of PhK is therefore of great interest to better understand 
glycogen metabolism in both normal and pathological biology.  
The discovery of PhK, which was the first protein kinase to be isolated and characterized 
in 1955, was a seminal event in the history of biochemistry. Although PhK has been studied for 
63 years, it remains a challenging enzyme to work with, in part because of its large size. The 
enzyme complex has a mass of 1.3 MDa and contains 16-subunits composing four () 
tetramers. Currently, we have no high resolution structures of the hexadecameric complex, but 
decades of structural studies using lower-resolution methods have revealed the likely 
arrangement of the subunits in the complex and subunit-subunit changes associated with 
activation. The  subunit is the catalytic subunit and has a typical kinase domain, based on 
sequence similarity and crystal structures of isolated, truncated . The remaining three subunits, 
which comprise over 80% of PhK’s mass, are the regulatory , , and  subunits. The regulatory 
subunits inhibit  in the non-activated complex and are the targets of allosteric effectors and 
reversible phosphorylation. A great deal of work still needs to be done to delineate the 
structures and regulatory mechanisms of , , and . The goal of this work was to revisit several 
aspects of PhK’s activity and explore new and expanded roles for the enzyme’s individual 
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subunits. The work presented here gives new insights regarding the participation of specific 
subunits in PhK’s activation and substrate recognition.  
PhK is activated by phosphorylation of the N-termini of the  subunits. The results 
presented in chapter II from the oxidative crosslinking of the  subunits link two important events 
in the activation of PhK: stimulation of the catalytic  subunit and changes in intra- subunit 
interactions. These results argue for a critical role of the N-terminus of  in inhibiting  in the 
non-activated complex and mediating important structural changes upon its phosphorylation. 
Future work looking at the specific inhibitory interactions between  and  would help expand 
our proposed model for activation. As methods to express multi-subunit complexes like PhK 
continue to advance, mutagenesis of  and  may provide new ways to probe their interaction. 
Prior to the work presented in chapter III, very little was known about the binding 
interface between PhK and its protein substrate GP. Other than the obligatory interaction 
between the phosphorylation site on GP and the active site on the subunit, there was no direct 
evidence for interactions between GP and any of the remaining regions of PhK. Other protein 
kinases are known to have docking sites that bind substrates at locations separate from the site 
of phosphorylation. These docking sites often vary from one protein kinase to another and can 
play important roles in the binding and phosphorylation of substrates. The discovery of direct 
interactions between GP and the regulatory  and  subunits establishes that there are 
substrate docking sites on PhK. The  and  subunits, along with , comprise the GP binding 
interface, but much work is left to be done to define the exact binding sites. In the future, 
chemical crosslinking coupled with mass spectrometry could reveal the exact residues between 
GP and PhK that crosslink with one another. The location of these residues may give important 
clues as to how these docking sites on  and  assist in substrate binding and phosphorylation. 
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PhK was previously found to undergo surprising activation between the standard assay 
temperature of 30 °C and the rabbits’ physiological temperature of 40 °C. In chapter IV, 
evidence is presented for a temperature-dependent conformational change in the  and  
subunits between 30 and 40 °C. The observation of conformational changes in the  subunit is 
consistent with the model for activation of PhK presented in chapter II and suggests that 
conformational changes in  are a common feature of PhK activation. Several aspects of PhK’s 
activity are changed at the higher temperature. For example, at 30 °C, non-activated PhK 
displays hysteretic behavior, but at 40 °C, the hysteresis is nearly abolished. Without the 
hysteretic behavior, which has hindered kinetic studies of PhK in the past, we studied the 
activation of PhK by phosphorylation at physiological temperature in terms of its kinetic 
parameters. Phosphorylation of PhK at 40 °C appears to coincide with an increase in Vmax and 
a small increase in the Km for GP. Additionally, the substrate saturation data were best fit to the 
Hill equation, suggesting that there may be some cooperativity in GP binding to PhK. For over 
60 years, PhK has been studied almost exclusively at 30 °C. Given the surprising differences in 
the enzyme at physiological temperature, everything we have learned about PhK’s structure, 
activity, and regulation should be re-considered in light of these findings. Undertaking these 




Appendix: Screening Kinases 
Introduction 
 Protein kinases comprise a large family of enzymes that mediate cellular signaling 
processes. The human genome is estimated to contain 518 such kinases, constituting about 
1.7% of all human genes (176). All protein kinases share a conserved sequence of 
approximately 300 residues and a highly conserved bilobal structure. Protein kinases carry out 
the phosphorylation of protein targets, often on Ser, Thr, or Tyr residues, but phosphorylation of 
additional amino acids, such as His, has also been reported (177). The phosphorylation of 
target sequences and the subsequent alteration of that target’s structure and/or activity allows 
kinases to regulate diverse cellular processes, such as cell proliferation, insulin signaling, 
inflammatory responses, and sugar metabolism.  
Efficient signal transduction requires cellular kinases to display a considerable amount of 
substrate selectivity. Some kinases are reported to be less selective than others, 
phosphorylating several proteins. For example, the  isoform of CK1 (formerly known as casein 
kinase) phosphorylates 14 protein targets in vivo and in vitro (178). On the other hand, 
phosphorylase kinase (PhK) is reported to phosphorylate only one protein in vivo, glycogen 
phosphorylase (GP). The factors governing kinase substrate specificity are not fully understood. 
Known substrates typically contain a sequence that matches a kinase’s consensus sequence, 
but another protein with the same exact sequence may not be a substrate for the same kinase. 
This inability to identify kinase substrates based on sequence alone has important implications 
for researchers. At this time, there is no straightforward method to identify kinases that 
phosphorylate a given protein target.  
 There are several different approaches to screening kinases for the ability to 
phosphorylate a protein target; each approach has pros and cons associated with it that should 
be carefully considered. 
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1. In silico prediction of kinases that phosphorylate a target protein. Several 
programs exist to predict kinases that phosphorylate a given protein sequence. Using 
these predication programs is a fast and convenient way to identify candidate kinases 
that have consensus sequences within a protein of interest. In silico prediction of bona 
fide protein kinases is speculative, however, and any candidate kinases must be 
experimentally validated. 
2. Kinase inhibitor libraries. Pharmacological inhibition of kinases by small molecules is a 
large area of research, and several kinases have relatively selective inhibitors 
commercially available. Phosphorylation of a target protein may be monitored in lysates 
or cells in the presence and absence of selective kinase inhibitors. Inhibition of substrate 
phosphorylation by a given inhibitor may indicate which kinase(s) target the protein of 
interest. This approach requires a method to reliably measure substrate phosphorylation 
in a lysate and likely requires additional validation with purified kinase. 
3. Co-immunoprecipitation (co-IP) coupled to mass spectrometry. Potential binding 
partners of a protein of interest can be identified using co-IP and mass spectrometry. 
Among the proteins pulled down with the protein of interest may be a kinase that could 
phosphorylate the target protein. If a kinase is identified, it would still require secondary 
validation of both interaction and phosphorylation. Additionally, kinase-substrate 
interactions may be fleeting and not be captured by co-IP. 
4. Direct screening using purified kinases. Purified kinases can be directly screened by 
measuring phosphorylation of a target protein in vitro. This is a laborious approach, but 
one that produces immediate results. Screening kinases with this approach takes time, 
careful consideration of individual kinase regulation and activity, and requires purified 
kinase, which can be challenging to produce and costly to purchase.  
 Phosphorylation of the hexadecameric PhK complex, ()4, by cAMP-dependent 
protein kinase (PKA) or by PhK itself via autophosphorylation stimulates its activity. Non-
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activated PhK purified from rabbit muscle, however, already contains several moles of 
phosphate in the non-activated complex (179, 180). It is not clear if this “endogenous” 
phosphate is incorporated in vivo by PKA, autophosphorylation, or some other kinase(s).  
A recent study suggests that PhK exhibits a small glycosyl hydrolase activity, likely at an 
active site in the glucoamylase-like domain of the  subunit of PhK (66). The  subunit contains 
a short multiphosphorylation domain in its C-terminus, and phosphorylation of  only modestly 
stimulates PhK activity (104). It is therefore of interest to determine if any kinases, other than 
PKA or PhK, selectively phosphorylate  and if that phosphorylation stimulates PhK’s hydrolase 
activity.  
 PhK’s own substrate, GP is reported only to be phosphorylated by PhK. This notion of a 
single GP kinase has been held for over 60 years without being systematically tested. 
Additionally, the phosphorylation site at the N-terminus of GP is predicted by in silico methods to 
be targeted by several additional kinases, including PKC and PKA.  
 Herein, multiple protein kinases were screened for the ability to phosphorylate PhK and 
GP using a direct approach to measure the transfer of the  phosphoryl group of ATP to PhK or 
GP by purified protein kinases or partially purified muscle lysate. 
Results and Discussion 
Phosphorylation of PhK by Purified Kinases 
PhK was screened as a substrate for six kinases: CK1, GSK3, Cdk5, PKG1, Akt2, 
and AMPK2. The major challenge in the design and analysis of these experiments was the 
potentially high background caused by PhK autophosphorylation during the course of the 
experiment. Ca2+ is required for PhK activity (42) and was therefore excluded in the kinase 
screening assays to minimize autophosphorylation, especially given the high concentrations of 
PhK present in the assay. Despite the exclusion of Ca2+, Ca2+-independent autophosphorylation 
was clearly present throughout the kinase screen (Figure 5.1, open circles). The reason for the 
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Ca2+-independent autophosphorylation is not known. Although the autophosphorylation is 
clearly present, it is much slower (~10-fold less) than the Ca2+-dependent activity normally 
observed with PhK (data not shown). In the future, pending technical advancements in 
recombinant protein expression of large, multi-subunit proteins, expression of a kinase-dead 
PhK would allow for proper screening of novel PhK kinases without the complication of 
background autophosphorylation. 
 AMPK2, GSK3, Cdk5, and Akt2 showed no apparent phosphorylation of PhK under 
the conditions tested. As an example, PhK phosphorylation with and without Akt2 is shown in 
the bottom panel of Figure 5.1. AMPK was previously reported to not phosphorylate PhK (181), 
consistent with the results presented here. GSK3 did not phosphorylate PhK, but is known to 
prefer substrates that already possess a phosphoserine near the target residue (182). 
Therefore, GSK3 could perhaps phosphorylate PhK after an appropriate priming 
phosphorylation event by another kinase and thus cannot yet be eliminated as a potential PhK 
kinase. CK1 does appear to cause a slight increase in the phosphorylation of PhK (Figure 5.1, 
top), however this increase is very modest. 
PKG1, on the other hand, displayed relatively robust phosphorylation of PhK (Figure 
5.2). Incorporation of phosphate into PhK’s individual subunits was determined using SDS-
PAGE to separate the PhK subunits for analysis. PKG1 appeared to phosphorylate both  and 
, similar to PKA, and no phosphorylation of the  or  subunits of PhK was detected. 
Importantly, cGMP, the essential activator for PKG1, did not stimulate PhK 




































































Figure 5.1 Screening PhK as a Substrate for CK1 (top) and Akt2 (bottom). The reactions 
were performed as described under Materials and Methods. The closed circles are reactions 
containing CK1 (top) or Akt2 (bottom). Controls without CK1 or Akt2 were performed to 
determine PhK autophosphorylation (open circles). Error bars represent the standard 
deviation of triplicate samples. 
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Figure 5.2 Phosphorylation of the (top) and (middle) subunits of PhK by PKG1. PhK was 
phosphorylated and run on an SDS-PAGE gel as described under Materials and Methods. The 
reaction contained 25 mM Tris/GP (pH 7.0), 0.5 mM EGTA, 0.1 mM DTT, 350 μg/mL PhK, 0. 
1μM cGMP, 15 μg/mL PKG1, 2 mM Mg(OAc)2, and 0.1 mM [-32P]ATP. PKG1 phosphorylated 
PhK (closed circles) above the levels of autophosphorylation when PKG1 was absent (open 
circles). PhK autophosphorylation was also tested in the absence (open squares) and presence 
(closed squares) of 1 μM cGMP and showed no difference (bottom). Error bars represent the 


















































































increase in phosphorylation was due to PKG1 and not cGMP-induced autophosphorylation. 
PhK’s recently discovered glycosyl hydrolase activity was not stimulated by PKG1 
phosphorylation in a separate series of experiments.  
PKG was previously identified as a PhK kinase (183) in agreement with the results 
presented here. Studying the influence of PKG1 phosphorylation on PhK’s kinase activity in 
vitro and in vivo in the future will be essential in determining the biological significance of this 
phosphorylation event. 
Screening for PhK Kinases in Partially Purified Muscle Lysates 
Partially purified muscle lysate was also screened for endogenous kinases that 
phosphorylate purified PhK. During the standard purification protocol, PhK is separated from the 
bulk of the muscle tissue lysate by acid precipitation. The large quantity of supernatant that is 
generally discarded contains the majority of soluble muscle proteins but lacks PhK. The 
supernatant was dialyzed into 20 mM HEPES (pH 7.0) to remove small molecules and PhK 
phosphorylation was measured in the absence and presence of 3.5 mg/mL lysate. For these 
experiments, high background counts from the lysate were avoided by isolating PhK’s  and  
subunits using SDS-PAGE. Phosphorylation of PhK was stimulated modestly by addition of the 
lysate (data not shown). Different effectors were added into the reaction to see if general types 
of kinases could be identified as potential PhK kinases. Ca2+ was tested as an effector and 
stimulated lysate phosphorylation of the  and  subunits above the level of 
autophosphorylation by Ca2+-activated PhK alone (Figure 5.3). This increase in phosphorylation 
may be due to a Ca2+-dependent kinase or activation of PhK by exogenous calmodulin (CaM), 
which is well-documented (184, 185). Purified PKC, a Ca2+-dependent kinase, was screened 
as a putative PhK kinase but was not found to phosphorylate PhK. 
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Figure 5.3 Phosphorylation of the (top) and (bottom) subunits of PhK by partially purified 
muscle lysate in the presence of Ca2+. PhK was phosphorylated by 3.5 mg/mL lysate in the 
presence of 1 mM CaCl2 and run on an SDS-PAGE gel as described under Materials and 



























































It may be that PhK is phosphorylated by another isoform of PKC, another Ca2+- or CaM-
dependent kinase that wasn’t tested here, or is simply being activated by exogenous CaM. 
Phosphorylation of GP by Purified Kinases 
 GP was screened as a substrate for nine kinases: Akt2, GSK3, Cdk5, AMPK2, CK1, 
PKA, PKC, PKC, and PKC. GP has one known phosphorylation site at its N-terminus, 
Ser14, that is predicted to be solvent exposed and flexible. Computational prediction of kinases 
that phosphorylate Ser14 using programs such as NetPhos or GPS (186, 187) suggests that 
Ser14 is a potential substrate for several kinases other than PhK. In particular, PKC was 
particularly favored as a potential GP kinase. 
 From the initial screen of Akt2, GSK3, Cdk5, AMPK2, CK, and PKC, only PKC 
appeared to phosphorylate GP, but only to a small degree (Figure 5.4). Two additional isoforms 
of PKC were then tested and failed to phosphorylate GP more than observed with PKC. PhK 
was included in the kinase panel as a positive control for GP phosphorylation. After 10 min, the 
phosphorylation of GP by PKC and PhK was similar (0.012 vs. 0.013 mol P/mol GP), but 
PhK far outpaces PKC phosphorylation by 60 min (Figure 5.4, middle). PhK-phosphorylated 
GP catalyzes AMP-independent activity, but when GP was phosphorylated by PKC for 10 min, 
no stimulation of GP’s AMP-independent activity was observed (Figure 5.4, bottom). This may 
imply that PKC phosphorylates an entirely different site on GP. 
 GP was also tested as a protein substrate for PKA. While full length GP is not typically a 
substrate for PKA (72, 188), a tetradecapeptide corresponding to residues 5-18 of GP, 
containing the phosphorylatable Ser14, is as good of a substrate for PKA as for PhK, 
suggesting that secondary or tertiary features of the full-length protein somehow block PKA 
phosphorylation (92). Previous groups have posited that GP may become a substrate for PKA in 
the presence of GP effectors 
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Figure 5.4 Screening kinases for the ability to phosphorylate GP. GP was screened (top and 
middle) as a substrate for CK1, Akt2, GSK3, AMPK2, Cdk5, PKC, PKC, and PKC as 
described under Materials and Methods. PhK was included as a positive control for GP 
phosphorylation. Bottom, GP’s AMP-dependent (dashed bars) and AMP-independent (gray 
bars) activities measured after phosphorylation by PKC or PhK for 10 min. The 
phosphorylation reaction was quenched with EDTA (final concentration 10 mM) and GP was 
diluted in cold 20 mM MOPS (pH 6.8) before being assayed as described under Materials 
and Methods. Control GP was not phosphorylated for comparison. Error bars represent the 





























































































known to alter GP’s conformation (19, 72). Tessmer et al. (72) tested PKA phosphorylation of 
GP in the presence of multiple GP effectors and salts. Under no conditions tested did PKA 
phosphorylate GP or apo-GP, which lacks its essential PLP group. Recently, however, Biorn et 
al. (93) demonstrated that PKA could slowly phosphorylate a mutant GP with a single Ala 
mutation at Arg16, two residues C-terminal (P+2) to the phosphorylation site. Although an Arg at 
the P+2 position is favored by PhK and disfavored by PKA (189, 190), the fact that a single 
residue change could permit PKA phosphorylation was intriguing. It seemed reasonable 
therefore to revisit the potential phosphorylation of wild-type GP by PKA in the presence of GP 
effectors, including some previously tested (AMP, glucose-6-P, and glycogen (72)) as well as 
some never-before tested (inosine monophosphate (IMP), uridine diphosphate glucose (UDPG), 
and glucose). In the presence of near-saturating amounts of these GP effectors, GP was not 
phosphorylated by PKA under any conditions tested (data not shown). In agreement with earlier 
studies, PKA cannot phosphorylate Ser14 on GP, despite its ability to phosphorylate a 
corresponding tetradecapeptide. This further supports the hypothetical existence of a structural 
feature on full-length GP that sterically blocks or otherwise impairs phosphorylation of its N-
terminus by PKA.  
Materials and Methods 
The kinases included in the screen were: His6-tagged PKG1 from EMD Millipore, GST 
tagged CK1 from Abcam, GST-tagged GSK3 from Abcam, His6-tagged AMPK2 from 
Abcam, His6-tagged Cdk5:p35 from Invitrogen, AKT2 from Abcam, PKC from Abcam, the 
catalytic subunit of PKA from New England Biolabs, and GST-tagged PKC, , and  from 
SignalChem. 
Non-activated PhK was purified from New Zealand White rabbit psoas muscle as 
previously described (75), dialyzed into 50 mM HEPES (pH 6.8), 0.2 mM EDTA, and 10% 
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sucrose (w/v), and stored at -80 °C. GP was also isolated from New Zealand White rabbit 
muscle as described previously (34) and recrystallized with Mg2+ and AMP. 
The PKC activation mixture containing lipids and Ca2+ was purchased from SignalChem. 
The remaining reagents were purchased through Sigma Aldrich or Fisher Scientific. 
Phosphorylation of PhK  
Most kinase assays were performed using a radioactive filter paper assay (175). PhK 
autophosphorylation in the absence of additional kinases was monitored as a control in all 
reactions. In all experiments, assays were initiated with the addition of MgATP and performed at 
30 C. For CK1, PKC, Akt2, and PKG1 the reaction mixture contained 25-50 mM Tris/GP 
(pH 7.0-7.5), 0.1 mM EGTA, 0.1 mM DTT, 300-350 μg/mL PhK, 1-4 μg/mL kinase, 1-2 mM 
Mg(OAc)2, and 0.1 mM [-32P]ATP. The reactions containing PKC also contained 0.15 mM 
CaCl2, 0.1 mM 1,2-diaceyl-sn-glycero-3-phospho-L serine, and 0.01 mM 1,2-dioleoyl-sn-
glycerol, and reactions containing PKG1 contained 0.1 M cGMP. Samples were collected 
from the reactions up to 45 min post-initiation.  
AMPK2, GSK3, and Cdk5 assays were also initiated with the addition of MgATP, and 
the final concentrations were 40 mM BGP (pH 7.0), 0.5 mM EDTA, 50 mM NaF, 0.1 mM DTT, 
1.5 mM Mg(OAc)2, 0.25 mM [-32P]ATP, 500 g/mL PhK, and 1 g/mL kinase. For AMPK2 
reactions, 0.25 mM AMP was also included. Reactions were carried out at 30 C for 30 min.  
When possible, positive phosphorylation controls were performed with known protein 
substrates to demonstrate that the kinases were active under the conditions tested. Such 
controls were performed with PKC, Cdk5, and CK1 and they were found to robustly 
phosphorylate their known substrates. 
The supernatant from the acid precipitation step in the PhK purification protocol was 
dialyzed into 20 mM HEPES (pH 7.0) and used as a source of endogenous muscle kinases. 
The total protein concentration of the partially purified lysate was determined by a BCA assay, 
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and phosphorylation of PhK was measured in the absence and presence of the lysate. The 
reactions were initiated by addition of MgATP and contained 20 mM Tris/GP (pH 6.8), 0.5 mM 
EGTA, 50 mM NaF, 0.1 mM DTT, 350 g/mL PhK, 4 mM Mg(OAc)2, 3.5 mg/mL lysate, and 1 
mM [-32P]ATP. When included, the concentration of CaCl2 was 1 mM. Reactions were carried 
out at 30 C for up to 30 min. 
Phosphate incorporation into the  and  subunits of PhK by PKG1 or partially purified 
muscle lysate was performed by quenching the reactions in SDS buffer and running the 
samples on a 6-18% SDS-PAGE gel as described previously (124). After running the samples 
on a 6–18% gels, staining, and destaining, the  and  bands were excised, decolorized in 350 
μL 30% H2O2 at 104 °C for 1 h, and diluted in 4 mL scintillation fluid.  
For the initial screen, only one preparation of PhK was tested as a substrate. When 
phosphorylation was detected (i.e., PKG1 phosphorylation of PhK) the experiment was 
repeated with a separate preparation of PhK to confirm reproducibility. Deviations from any of 
the methods described above are indicated in the figure legends. 
Phosphorylation of GP 
GP was tested as a substrate for nine kinases: AMPK2, Akt2, GSK3, CK1, Cdk5, 
PKA, PKC, PKC, and PKC. Reactions were initiated with addition of MgATP and the final 
reaction mixture contained 20 mM HEPES (pH 7.4), 0.1 mM EDTA, 0.1 mM DTT, 5  mg/mL GP, 
5 g/mL kinase, 10 mM Mg(OAc)2, and 1 mM [-32P]ATP. When PKC isoforms were tested, a 
PKC activator cocktail containing Ca2+ and lipids was included. When AMPK2 was tested, 1.5 
mM AMP was included. The reaction proceeded at 30 C and samples were collected at 10 and 
60 min to measure phosphate incorporation.  
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Positive phosphorylation controls were performed for PKC, PKC, and PKC with 
histone as the protein substrate and demonstrated that these kinases were active under the 
conditions tested. 
GP was also tested as a substrate for PKA in the presence of different GP effectors. The 
reactions were initiated with addition of MgATP and included 20 mM Tris (pH 7.4), 0.1 mM 
EDTA, 5 μg/mL PKA, 0.5 mg/mL GP, 10 mM Mg(OAc)2, and 0.5 mM [-32P]ATP. When added to 
the reaction individually, the final concentrations of GP effectors were 2 mg/mL glycogen, 1 mM 
AMP, 25 mM UDPG, 7 mM IMP, 0.1 mM glucose-6-P, and 8.5 mM glucose. These 
concentrations are 10-fold higher than the reported Ki/Ka for these GP effectors. The reactions 
proceeded for 10 min at 30 C. 
GP Activity 
GP was assayed in the direction of glycogen synthesis by quantifying phosphate cleaved 
from glucose-1-P. The assay was initiated with addition of GP and the final reaction solution 
contained 20 mM MOPS (pH 6.8), 2.5 mM glucose-1-P, 0.1 mg/mL glycogen, and 10 μg/mL GP. 
When present, the concentration of AMP was 1 mM. The glycogen, purchased from Sigma, was 
further purified by ethanol precipitation and dialysis to remove contaminating nucleotides and 
phosphate. GP was assayed for 5 min at 30 °C and 20 L aliquots were quenched by addition 
of 1 mL of freshly prepared malachite green reagent (0.12 mM malachite green, 2.25 mM 
ammonium molybdate, 830 mM H2SO4, 0.02% PVA). The malachite green reaction was allowed 
to develop for 10 or 12 min and the absorbance at A630 was measured. The color development 
was continuous, so the A630 measurements were carefully timed. A standard phosphate curve 
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